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Background: radiation medical imaging is a valuable tool in detecting diseases. 
Biological Effects of Ionizing Radiation Report (BEIR VII Phase 2) suggested that radiation 
exposures, even at low dosages, may impose stochastic cancer risks. However, radiation 
medical imaging has yet been fully understood; further studies on this subject are much 
needed. Over several decades, there have been much research dedicated to studying the 
impact of low-dose diagnostic imaging on health, particularly in the children population. 
Purpose:  This scoping review is to gather existing literature on the cancer risks associated 
with radiation medical imaging in children, and to identify gaps in the literature for future 
studies on this topic. Methods: Scopus and PubMed databases were selected for the literature 
search and the scoping review methodology was applied in this research. Results: The study 
has spanned over three thousand articles (N=3,191) and by applying the exclusion and 
inclusion criteria, twelve (12) articles have been chosen for this research. The research data 
suggested that exposure to (a) dental X-rays may be linked with thyroid cancer; due to limited 
research that had been conducted, more studies are needed to provide clearer understanding 
of the health impacts, (b) X-rays may not have any association with cancer, again, more 
research is required on this subject, (c) computed tomography scans may be linked to various 
cancers including thyroid, leukemia, solid cancer, and cancer mortality, and (d) angiography, 
based on mathematical cancer risk model, seems to suggest there are possible cancer risk. 
Today, there have been no studies performed on patient-level. Conclusion: The research 
indicates that there are potential cancer risks associated with dental x-ray, angiography 
(mathematical model), and CT scans; however, due to limited research that has been 
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performed up to this point, further studies are required on cancer risks from radiation medical 
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CHAPTER 1: INTRODUCTION 
Medical diagnostic imaging is a valuable tool in the diagnosis of illness and diseases. 
The tool is used to generate visuals of human bones, organs, and tissues; otherwise, it may be 
challenging to identify health issues. Commonly used medical imaging modalities include X-
rays, fluoroscopy, angiography, mammography, computed tomography (CT) scan, magnetic 
resonance imaging (MRI), ultrasonography (ultrasound), positron emission tomography (PET), 
and single photon emission tomography (SPECT).  Some modalities use ionizing radiation; 
therefore, they may have harmful effects on human health. X-rays, fluoroscopy, angiography, 
mammography, CT scans, PET, and SPECT all use energy sources such as X-rays and gamma-
rays (Canadian Association of Radiologist, 2013). 
Since the discovery of X-rays in 1895, radiography has been used in medical diagnosis 
and radiation therapy. Although there have been tremendous benefits in utilizing radiation in 
medical imaging, unfortunately, such irradiation exposures can be dangerous to human health 
(CRP, 2011). Early hypotheses indicated that irradiation may cause chromosome aberration 
and such aberration could lead to: 1) reconstitution of the chromosome, 2) rejoining with 
another broken chromosome, or 3) remaining broken (National Research Council, 2006). The 
illegitimate rejoining of chromosomes may lead to DNA mutation, which may occur in any 
person including adults and children; however, the greatest impact is on young children 
(Iacob, 2002). Due to the rapid cell changes in children, the probability of DNA mutation may 





Figure 1. Pediatric Medical Imaging Usage Trend 
 
Figure 2. Pediatric CT Scan Usage Trend 
 
Figure 1 & 2 show examples of computed tomography usage trends in the United 
States and Canada (Mettler, 2009; Smith-Bindman, 2012; Migliorettti, 2013; Inman, 2015; and 
Repplinger, 2016). Depending on the studies, medical imaging usage trends may differ. Due to 
the potential risk of CT scans, particularly in children, much emphasis and effort were placed 
in minimizing CT scan usage and reducing radiation doses (Inman, 2015). Reported in BEIR VII 
(National Research Council U.S., 2006), studies of health effects of ionizing radiation 
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suggested that exposure to ionization may lead to the development of solid cancers, 
leukemia, and cancer mortality. Furthermore, the report indicated that females were more at 
risk for all solid cancer in contrast to males, 1300 versus 800 per 100,000 persons, 
respectively. Secondly, females were less at risk of developing leukemia compared to males, 
70 versus 100 per 100,000 persons, respectively. Lastly, it was estimated that the lifetime 
attributable risk of developing solid cancer or leukemia was 1 in 100,000 persons in the 
general population, at an exposed dose of 100 milli-Sievert (mSv). From an epidemiological 
perspective, the report suggests that there might be associations between radiation 
exposures and cancer outcomes. With such concerns, the World Health Organization co-
sponsored a medical radiation protection conference in Bonn Germany (WHO, 2012) and 
offered a list of recommendations (known as Bonn Call-for-Action). The recommendations 
include 1) raising awareness of potential health risks, 2) promoting patient radiation safely, 
and 3) implementing guidelines for appropriate radiation medical imaging usages.  
Since the BEIR VII publication in 2006, there have been many studies on the possible 
association between ionizing radiation exposure and cancer risks. However, most of these 
investigations primarily focus on the overall population. As indicated earlier, radiation 
exposure, even at low doses, may be carcinogenic in children; thus, it is imperative that more 
investigations were conducted on such groups. Hence, the purpose of this scoping review is to 
gather patient-level studies that examined exposures to medical imaging and possible cancer 
risks in children. The goals are to identify the possible risks associated with diagnostic 
modalities that involve ionizing radiation and research gaps in this domain. Some of the key 
search concepts include diagnostic modalities, age at exposure, exposure doses, exposed 
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organs, cancer types, and possible cancer risks. These concepts are to be used for literature 
search and will be part of the data collection and analysis.   
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CHAPTER 2: LITERATURE REVIEW 
Radiology Overview 
X-rays were discovered in 1895 by Professor Wilhelm Conrad Roentgen at Wurzburg 
University in Germany. While working on his cathode-ray tube experiment, he observed a 
fluorescent glowing image on a nearby table. He then covered the tube with a solid black 
paper and noticed the light still protruded through the paper. His experiment revealed that X-
rays passing through objects of lower absorption rate will project blackened figures of the 
objects; however, with objects of higher absorption rate, a whitened figure of the object is 
cast instead. Roentgen later captured the bone structure of his wife’s hand on an x-ray film 
and that was the start of medical diagnostic imaging (Reed, 2011; and Iacob, 2002). Figure 3 
provides the components of an irradiation machine such as the X-ray machine. The diagram 
shows that the X-ray tube emits X-ray photons toward the irradiant object, such as a patient’s 
body. Behind the irradiant object is a detector such as a photographic film or digital detector, 
which is used to capture the studied images in two-dimensional views. There are other 
diagnostics tools that do not use radiation as an energy source and these will not be discussed 










Figure 3. X-ray Machine 
 
Health professionals often use medical imaging as a tool to diagnose health issues by 
visualizing organs, tissues, and bones that are internal and/or beneath the skin. There are 
many types of medical imaging techniques and processes used to achieve specific results. 
Table 1 lists commonly used medical imaging techniques that involve ionizing radiation.  
7 
 
Table 1. Medical Imaging Techniques 
Techniques Description Energy Source and 
Estimated Radiation 
Dose 
Examples of Clinical Application 
X-rays use ionizing radiation to generate 
still images of human internal 
structures such as bones, organs, 
and tissues 
X-rays 
Chest: 0.025 mSv 
Dental: 0.008 – 0.01 mSv 
lung and bone pathologies, fractures, 
infections, abdomen air or fluid, or dental 
cavities 
 
Fluoroscopy produces continuous X-rays images 
of the body structure via passing 
an X-ray beam through the body. 
Can be done with contrast dye 
moving through the body during 
examinations or insertion of a 
catheter through blood vessels, 
bile ducts or urinary system 
X-rays 
Chest ~1 mSv 
Cerebral Angiogram ~7 
mSv 
 
gastrointestinal tract or uterine cavity 
evaluations, Orthopedic surgery, 
Placement of devices within the body, 
vascular diseases, aneurysms, or bleeding 
vessels 
Mammography produces images of breast tissues 
 
X-rays 
Breast screening: 0.1 - 
0.4 mSv 




produce a series of images; 
computer algorithms are then used 
to render the images into two- or 
three-dimensional views as 
required 
X-rays 
Body: 6.9 – 14.2 mSv 
Head: 0.7 -2.6 mSv 
e.g., brain, cranium, head or neck, chest, 







PET and SPECT inject radioactive 
tracers into the body to detect 
cancerous tissues and cells. The 
difference between PET and SPECT 
modalities are the type of 
radioactive tracers being used 
Gamma rays and X-rays 
12 – 33 mSv 
e.g. cancer tissues or cells 
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This study focuses specifically on low-dose ionizing radiation medical imaging exposures 
in children; hence, non-ionizing radiation medical imaging techniques such as MRI and 
ultrasound will be excluded. X-rays, which are a type of high energy light rays, consists of the 
shorter wavelength of 10-10 Hz that pass through non-metallic objects such as the human 
body. When X-rays project through a human body, they produce two different images 
depending on the objects’ density. For softer tissues, such as a lung, a blackened figure on a 
photographic plate is generated when the X-rays pass through the organs. For higher density 
objects, such as bones and hearts, a whitened figure is produced instead (Figure 4).  
In CT scans, computer-aided machines are used to capture multiple X-ray slices of the 
body parts and then reconstruct the images to produce two- or three-dimensional views of 
the body parts. Likewise, in mammography, these machines are designed to capture images of 
breast tissues and structure.   




Dosimetry and Reporting 
Depending on the examined body part, as discussed previously, there are various types 
of diagnostic modalities and machinery. The goal of irradiation medical imaging has always 
been to minimize the dosage to which the patient is exposed without misdiagnosis. This 
practice is commonly referred to As-Low-As-Reasonably-Achievable (ALARA).  
Determining the amount of radiation exposure and its biological effects is a highly 
complex process. The amount of ionizing radiation emitted to the organs depends on many 
factors, see Figure 5 and Table 2. For example, when a patient receives a CT scan, the 
following attributes will need to be considered: (a) the amount of energy emitted (Computed 
Tomography Dose Index - CTDI), as denoted by the yellow square box, (b) the surface area of 
the human body exposed (Dose Length Product - DLP) as denoted by the yellow circle, (c) the 
number of slices per scan, (d) the organ and tissue radiosensitivity (tissue-weighting factors), 
and (e) the radiation-weighting factor such as X-rays, gamma rays, beta rays, or positron. All 
these variables need to be assessed in determining the dose equivalent and effective dose of 
the CT medical imaging procedure (Sprawls, 1993; and Sprawls and Duong, 2013).  
Depending on the patient’s age, gender, irradiated body parts, and radiation weight 
factor, the effective dose may vary (Deak, 2010; and ICRP, 2011). The effective dose is 
normally adjusted for the age of the patient and the radiosensitivity of the organs being 
examined. Hence, the effective dose for children is less than those for adults. Similarly, the 
effective doses for girls are reported slightly lower than for boys (Shi, 2016). Furthermore, 
cumulative dosages are used to measure the amount of radiation being administered over a 
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patient’s lifetime. Cumulative dose measurements are an important aspect in determining the 
stochastic effects of re-occurring exposures.  




Table 2. Ionizing Radiation Dose Measurements  
Measurement Description and Formula 
 
Photon 
(Curies or Becquerel) 
Small units of energy that are presented in electromagnetic 
radiation (light, X-ray, gamma, etc.) are called photons. The total 




(Roentgen – old unit) 
A concentrated quantity of radiation (measured in Roentgen 
unit) that is emitted by the medical imaging machine, 1 R = 2.58 
x 10 exp-4 C/Kg of air 
 
Dose Area Product 
(DAP) 
(Gy-cm2) 
Measurements of the total amount of radiation energy that is 
delivered to the irradiated area (body) in Gy-cm2 per series. 
DAP = absorbed dose * radiated area 
 
Dose Length Product 
(DLP) 
Measurements of the total radiation energy that is deposited in 
the human body per series 
 
DLP = CTDIvol (mGy) X length of scan (cm) 
 
Absorbed Dose 
(Gray or Rad) 
Measurements of the amount of irradiation energy (in 
Roentgen) deposited onto an object 
 
Absorbed Dose = Energy / mass (kg) 
1 rad = 100 ergs/g; 1 Gy = 1 Joule per Kg = 100 rads 
Absorbed Dose Measurement Units: 
X-rays = kVp; CT = CTDI (CT Dose Index) 
Equivalent Dose 
(Sievert or Rem) 
Measurements of the amount of energy absorbed by the 
irradiated tissues based on specified radiation types (e.g., alpha, 
beta, gamma, X-ray, neutron, etc.) 
 
Equivalent dose is the absorbed dose multiply by the radiation 
weighting factor (wR) 
Equivalent Dose (Sv) = Absorbed Dose (Gy) x wR 
e.g. of radiation weighting factor (wR): 
 
X and Y rays =1 
Electros = 1 
Neutrons = varies (5 to 20) 
Protons = 2-5 
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Measurements of the total amount of energy that is absorbed 
by the organs which included the weighting factor of organ 
radiation sensitivity 
 
1 Gray (Gy) = 1 Sievert (Sv) 
Effective dose is the sum of (equivalent doses) multiply by the 
radiation sensitivity weighting factor 
Effective Dose (Gy) = sum (Equivalent Dose (Gy)) x wT 
e.g., of radiation sensitivity weighting factor (wT) 




Measurements of the total amount of radiation that is exposed 




Most medical imaging equipment and Picture Archiving and Communication Systems 
(PACS) comply with ISO standards for data collection and transmission called Digital Imaging 
and Communications in Medicine (DICOM). A DICOM consists of two parts, DICOM Core 
(which consists of file format and networking protocol) and DICOM Objects (which contains 
clinical information). Since DICOM Core focuses mainly on the machinery aspect, it will not be 
discussed in this document. The DICOM Objects (Figure 5) store the following information: 
patient profile, study details, study series, equipment details, and instances (medical images). 
For patient health studies, the patient profile, study details, and equipment information 
contain the most important details (DICOM Standards Committee, 1999 and 2005). Radiology 
imaging details are stored in the DICOM Objects and the data is used for clinical purpose and 
health research. As shown in Figure 6, a patient may have many diagnostic imaging studies. A 
single study may contain multiple series, and a series may contain multiple images. For dose 
measurements (as mentioned in Table 2), doses were collected at the study-level and is 
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typically reported in the Radiation Dose Structure Report (Dose SR). The Dose SR contains the 
patient profiles (such as patient ID, name, date of birth, sex, weight, height, and location), 
medical imaging device information, and most importantly, the dose measurement details. 
Depending on the medical devices, they may capture information such as modality types, 
modality calibration information (photom sizes, computed tomography dose index (CTDI), 
etc.), dose length product, number of slice per series, etc. All these radiology data are critical 
in determining the absorbed, effective, equivalent, and/or cumulative doses of the radiology 
procedures.   
Figure 6. DICOM Structure & Radiation Dose Structure Report 
 
 
Dose-Responses (Deterministic and Stochastic) 
Deterministic or stochastic biological effects are measurements used in studies of 
ionizing radiation exposures and cancer outcomes on human (UNSEAR, 2008). Deterministic 
effects occur when a certain level of radiation (dose threshold) is exceeded and are mainly 
associated with higher radiation dose exposures (i.e., approximately above 200 mSv 
equivalent dose). In some cases, the deterministic effects can be observed within hours, and 
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in others; they can take months to emerge. Table 3 (Health Physics, 2004) demonstrates the 
effects such as skin erythema, cataracts, sterility, radiation sickness, and death. However, the 
carcinogenic effects of low dose exposures (less than 200 mSv effective doses) may or may 
not have a latency period of up to 20 years (stochastic effect). The focus of this research will 
be on low-dose medical imaging modalities. High ionizing radiation dose exposures are 
beyond the scope of this research. 




Radiation Exposure Risk Models and Risk Measures 
Over past decades, nuclear research organizations proposed a risk model based on the 
atomic bombs Life Span Studies (LSS) as shown in Figure 7. The model shows five different 
dose-response scenarios: 1) Supra-Linear, this model suggests that the exposure initially 
imposes a high level of risk; there is no threshold limit. However, the lifetime risk may be 
marginal. For example, children who have been exposed to CT scans may have a risk of 
Dose (mSv) Health Impacts Health effects 
0 - 200   No detectable immediate effects. 
 
200 - 1000 Blood-bone marrow effects, temporary decrease in 
white blood cell count 
 
1000 – 2000 
 
Eye effects (cataracts), skin effects (Skin Erythema), 
acute radiation sickness - nausea, vomiting, longer-
term of a decrease in white blood cells. 
 
2000 – 3000 Sterility, hair loss, vomiting, diarrhea, loss of 
appetite, listlessness, death in some cases.  
 
3000 – 6000 Gastrointestinal effects, immune system  
effects, vomiting, diarrhea, hemorrhaging, deaths 
are occurring in 50% of the cases at 350 rad or above 
without medical treatment. 
 
Above 6000 Thyroid effects, eventual death in almost all cases. 
 










developing leukemia within the first five years following the exposure; however, the risk may 
be reduced thereafter. 2) Linear-Quadratic, this model suggests that the exposure imposes a 
marginal level of risk; there is no threshold limit as well. However, repetitive exposures may 
elevate the risk exponentially. For example, a single CT scan may impose a relatively low level 
of solid cancer risk; however, repetitive CT scans may increase the level of developing solid 
cancer. 3) Linear No-Threshold, this model suggests that exposure will linearly increase the 
risk of cancer. Again, this model has no threshold limit. For example, children who have been 
exposed to a CT scan will have the odds ratio of 1.4 in developing thyroid cancer. The odds will 
increase in proportion to the increase of exposure dose. (4) Hormesis, this model suggests 
that a small exposure dose may reduce the risk of developing cancer. However, beyond a 
threshold dose, the risk will begin to increase. For example, a single x-ray procedure may lead 
to a negative risk of developing solid cancer (e.g., Relative Risk is 0.70). However, if exposed to 
five X-ray procedures will increase the risk (e.g., Relative Risk is 1.3). (5) Linear threshold, this 
model suggests that exposure to a low amount of radiation is considered risk-free; however, 
beyond a threshold, the risk will increase linearly. X-ray procedures may follow the pattern of 









Figure 7. Radiation Exposure Risk Models 
 
In addition, estimating cancer risk may be determined by different statistical methods 
(see Table 4). Depending on the studied objectives and desired results, the following cancer 
risk methods may be reported. The two most common indications for cancer risk estimates 
are cancer incidence rates and cancer risk probabilities (National Research Council, 2006). 
Depending on the research objectives, other risk and incidence indicators (e.g., Incidence Rate 











Risk LAR is an estimated probability of death or develops 
cancer from radiation exposure. It is a percent difference 




AR = (A – B)/A * 100 
 
A = incidence in the exposed person 
B = incidence in unexposed person 
 
The results are reported in the form of incidence rate per 
10,000 or 100, 000 persons. The higher incidence values 






The radiation-induced cancer death that is above the 
normal rate of death. 
 
ELD = n/N (u – u*) 
 
n= cancer patient population 
N= total population 
u= mortality in cancer patient population 
u*= mortality in the total population 
 
The results are expressed as excess cancer-related death 
in their lifetime in the percentage format. A high value 
implies a higher cancer risk. 
 




ERR is the risk of developing cancer from medical imaging 
exposure above the cancer risk from background radiation 
exposure. 
 
RR = (RR-1) 
 
The ERR is expressed as a positive figure which represents 
a value above the normal risk. A high value implies a 






EIR presents the number of the incident above the normal 







The results are expressed in the number of cases per 







SIR is the ratio of the observed number of cancer cases to 
the expected number of cases. The observed number of 
cases refer to several cancer cases in the cohort studies. 
The expected number of cases is a statistic computed 
reference study population (e.g., weighted age-specific 
data). 
 
For SIR>1, the results show the cancer incidence is greater 
for the observed than the expected cases. If the SIR<1 the 
results show the cancer incidence is greater for the 
expected than the observed cases. If the SIR=1.0 or 
approximately, there is no significant difference between 
the observed and expected cases. A value greater than 1 






IRR is the incidence rate ratio of the exposed versus 
unexposed, after stratification for age, sex, and year of 
birth. 
 
For IRR>1, the results show the cancer incidence is greater 
for the exposed than the unexpected groups. If the IRR<1 
the results show the cancer incidence is greater for the 
unexposed than the exposed groups. If the IRR=1.0 or 
approximately, there is no significant difference between 
the two groups. A value greater than 1 implies that there 
is a higher risk. 
 
Relative Risk (RR) Risk Ratio RR measures the probability that an exposed population 
will develop cancer relative to the probability of an 
unexposed population that will also develop cancer. 
 
RR = P (cancer /exposed) / P(cancer/unexposed) 
 
For RR>1, there is an increased risk of developing cancer 
among those that have been exposed. If the RR<1, the 
exposure may decrease the risk of developing cancer. In 
this case, exposure to radiation may provide health 
benefits (hormesis cancer model). If the RR=1 or 
approximately to 1, it implies that there is no association 







Odds Ratio (OR) Risk Ratio OR measures the odds of cancer in the exposed 
population over the odds of cancer in the unexposed 
population. OR is used to describe the association 
between the exposure and outcome. 
 
OR = [P (cancer/exposed) / (1 - P(cancer/exposed)] / [P 
(cancer/unexposed) / (1 - P(cancer/unexposed)] 
 
For OR>1, there are chances of developing cancer among 
those that have been exposed. If the OR<1, there are no 
possible chances of developing cancer amongst those that 
have been exposed. If the OR=1 or approximately to 1, it 
implies that there are no differences between the exposed 
and unexposed. 
 
Hazard Ratio (HR) Risk Ratio The hazard ratio is the radiation hazard in the exposed 
population over the radiation hazard in the unexposed 
population. Cox regression statistical method is commonly 
used for determining the HR. 
 
For HR>1, the results show the cancer incidence is greater 
for the exposed than the unexpected populations. If the 
HR<1, the results show the cancer incidence is greater for 
the unexposed than the exposed groups. If the HR=1.0 or 
approximately, there is no significant difference between 
the populations. A value greater than 1 implies that there 




Radiation Medical Imaging Exposures and Cancer Risks 
A study of child radiography in Romania (Iacob,2002) showed that chest, spine, pelvis, 
head, abdomen, limb, and joint X-rays were frequently prescribed to young children (from 
birth to age 15). Chest X-ray procedures have been one of the most common procedures, 
accounted for 60 percent of annual occurrences, with an average effective dose of 0.74 mSv 
annually (with a range of 0.53 mSv to 1.08 mSv). The benefits of X-ray procedures provide a 
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quick method for detection of abnormalities of the heart, lung diseases, rib fractures, airway 
obstructions, or fluid in the lungs. Young children are often prescribed X-rays as a diagnostic 
method for detecting health issues; otherwise, they may not be detectable by other means. 
Although X-rays (0.02 mSv – 8.0 mSv) and dental X-rays (0.005 to 0.01 mSv) emit very low 
radiation doses, according to the Linear-No-Threshold model, there are no amounts of 
radiation exposures that are considered as safe.  
Fluoroscopy is a diagnostic imaging method that continuously gathers X-ray images of 
internal organ studies. Fluoroscopy procedures include studies of the respiratory, 
gastrointestinal, and urinary tracts. Given that these procedures capture multiple X-ray 
images and have a longer examination time, fluoroscopy dose measurements may be higher, 
with the effective dosages ranging from 11.81 mSv to 16.45 mSv. The lifetime attribute risk 
from fluoroscopy procedures ranges from 0.2% to 0.8% (Huang, 2008). 
CT scans are another type of X-ray diagnostic imaging procedures, whereby cross-
sectional images are taken to provide three-dimensional images of the organs, tissues, bones, 
or blood vessels. Complementary to fluoroscopy or angiography, the purpose of CT scans is to 
detect internal organs and structure abnormalities, the growth of tumours, and injuries and 
traumas. The effective dose of a full-body spinal CT scan may range from 0.03 mSv to 70 mSv. 
The cancer risks from CT scans may impose non-cancer health issues as well as lifetime risks of 
developing solid cancer and leukemia. The next section will discuss cancer and non-cancer 
impacts in more detail.  
From the Life Span Study of Japanese atomic bomb survivors and nuclear accidents 
(Samartizis,2011; Kusunoki, 2008; Wang, 2016; Neriishi, 2007; Johnson, 2014; Rahu, 2014; and 
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Ivanov, 2000), there has been evidence of cancer and non-cancer adverse health effects. For 
non-cancer health effects, some of the illnesses may include diseases (e.g., blood, circulatory, 
respiratory, and digestive) and disorders (e.g., genitourinary, musculoskeletal, and mental). 
Many of non-cancer health effects may be linked to high-dose exposures, as in the case of 
exposures to atomic bombs, nuclear accidents, and radiation therapies. In addition, low-dose 
exposures may induce non-cancer health issues such as cardiovascular and respiratory 
diseases. For this research, non-cancer health impacts are also beyond the scope. 
 
Types of Childhood Cancers 
Our bodies are constantly exposed to the background and different types of radiations. 
During such exposures, some cells are damaged and destroyed; however, these cells are 
automatic repaired. During the repair process, sometimes the DNA stands are improperly 
formed, and the cells became defective. Consequently, DNA mutations may develop which 
potentially lead to the development of cancers (Iacob, 2002). Given that children are in a 
constant state of growth, there is a higher probability of DNA mutations. Second, children 
have more years of life; therefore, it is expected that the probability of lifetime cancer risk 
would be greater. According to the American Childhood Cancer Organization and Healthy 
Children, “Childhood cancer is the number one disease killer and the second overall leading 
cause of death of children in the United States. More than 10,000 children under the age of 15 
in the United States are diagnosed with cancer annually”. Table 5 provides a list of childhood 




Table 5. Types of Childhood Cancer 
Cancer Type 
 
Descriptions Childhood cancer ranking & 
incidence percentages 
Leukemias Leukemia is defined as the abnormal 
amount of white blood cells that are 
produced in the bone marrow. There 
are different types of leukemia: acute 
lymphoblastic leukemia (75%), acute 
myeloid leukemia (20%), juvenile 
myelomonocytic (rare), acute 
promyelocytic (rare), chronic 
lymphoblastic (rare) and chronic 
myeloid (rare). Leukemia is one of the 
most common types of childhood 
cancers (ages 2 to 20 years). 
 
Rank 1st 




acute myeloid leukemia – 5% 
 
 
Brain Cancers Brain cancer is defined as a form of a 
tumour in the brain area. There are 
different types of brain tumours, such 
as astrocytomas medulloblastomas 
and ependymomas. Brain cancers 




Brain and central nervous 
system – 21% 
Neuroblastoma Neuroblastoma is defined as solid 
cancer that forms in the nervous 
system. This cancer occurs from birth 
to 5 years old. 
 
Rank 3rd 
Neuroblastoma – 7% 
Lymphomas 
(Thyroid Cancer) 
Lymphoma is defined as cancer where 
abnormal white blood cells are found 
in the lymph system. There are two 
types of lymphoma cancers: Hodgkin 
and Non-Hodgkin. Lymphoma cancers 
are common in children ages 10-20 
years. Non-Hodgkin is the most 
common type of cancer. 
 
Rank 4th 




Hodgkin Lymphoma – 4% 
 
Wilms Tumor Wilms is defined as a form of kidney 




Wilms tumor 5% 
Bone Cancers Bone tumours are commonly found at 
the skull, shoulders, arms, knees, or 
Rank 6th 





Descriptions Childhood cancer ranking & 
incidence percentages 
pelvis. A common type of bone cancer 
is osteosarcoma. Bone cancers 




Sarcomas are abnormal growth of 
tumours (soft tissues in muscle, fat, 
fibrous tissue, blood vessels, tendons, 
etc.). Rhabdomyosarcoma appears in 
children from birth to 10 years old. 
 
Rank 8th 
Rhabdomyosarcoma – 3% 
Retinoblastoma Retinoblastoma is defined as a form of 
tumour, typically on the retinal layer 
of the eyes. It is typically found in 
children under the ages of 15. 
 
Rank 9th 
Retinoblastoma – 3% 
Hepatoblastoma Hepatoblastoma is a solid cancer of 
the liver. This cancer typically occurs 
in children under 4 years of age. 
 




Rhabdoid is defined as a rare form of a 
tumour. It is usually found in the 
cerebellum (near the brain region). 
Although this cancer is rare, it is a 
highly aggressive form of tumours. It 




Rhabdoid Tumors - Rare 
 
 
Sex differences in cancer susceptibility 
Dorak and Karpuzoglu studied the possibilities of sex differences in cancer 
susceptibility. Although the reasons remain enigmatic, Dorak and Karpuzoglu cited that there 
are several possible causes of cancer susceptibilities: chromosomes, hormones, and 
environmental factors. In childhood cancer, the study indicated that boys are at a higher 
lifetime attributable risk than girls; moreover, boys and girls are prone to different cancer 
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types. Due to the sex physiological variations, certain cancers have higher incidence rates 
between the sexes. For example, the incidence rate of Hodgkin Lymphoma (HL) is greater in 
girls than in boys, with a ratio of 4 males: 5 females. Sex chromosomes are another key sex 
difference as males carry a single X-chromosome whereas females carry a double XX- 
chromosome. In females, only one X-chromosome is used while the second X-chromosome is 
randomly inactivated. If an X-chromosome gene becomes damaged, females would have an 
advantage of having a second X-chromosome. This extra X-chromosome enables females to 
continue with normal functions such as protein production. Hormones are another key sex 
difference such that the body generates a greater amount of androgen in males, whereas it 
generates a greater amount of estrogen in females. Both androgen and estrogen fulfill a major 
function in the immune system, which leads to the capacity for protecting the body against 
cancer progression. For example, estrogen has been identified as a protection against 
colorectal cancer. In some cases, hormone therapy has been used for cancer treatments. 
Dorak and Karpuzoglu also cited that environmental factors play a greater role in cancer 
susceptibilities than that of genetics. Genetics may not be the primary factors “…genetic 
factors are more likely to be modifiers of susceptibility rather than primary determinants of 
susceptibility”. Although there have been advancements in the studies of sex-specific and 




CHAPTER 3: STUDY RATIONALE 
Radiation medical imaging is an effective technique in detecting health issues; however, 
radiation exposure may elevate the risk of developing cancer. It has been reported that the 
use of diagnostic imaging is on the rise in the last few decades (Mettler, 2009; Smith-Bindman, 
2012; Migliorettti, 2013; Inman, 2015; and Repplinger, 2016). Although (Inman, 2015) 
indicated that, in recent years, the usage of CT scans and the exposure dose may have been 
reduced.  
There were many studies that have been performed on cancer risks associated with 
radiation medical imaging (National Research Council, 2006); it is unclear how many studies 
were based on children. Evidence from the literature indicates that there have been 
deterministic cancer effects in high-dose irradiation exposures (above 200 mSv) and stochastic 
cancer effects in low-dose irradiation exposures (below 200 mSv). As indicated earlier, 
children’s bodies undergo continuous development and rapid growth, and children of ages 
less than five years are the group with the highest cancer risks.  
The purpose of this scoping review is to explore studies that have been conducted on 
radiation diagnostic imaging and cancer risks in children and to identify gaps in current 
literature. Depending on the available literature, this research will gather intelligence on this 
subject such as: what modalities may be associated with cancer, what factors are contributing 
to cancer risks, what are cancer incidence and risk probabilities, and are there possibly gender 
differences? These findings will help pave the path for future research.   
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CHAPTER 4: METHODOLOGY 
Research Methodology 
 Scoping Review methodology has been applied to this research (Arksey and O'Malley, 
2005). Upon formulating the search concepts and MeSH terms, they were used to query the 
search databases. The results of the literature search and triage are presented in the PRISMA 
diagram (Liberati, 2009). Sections below provide the details of literature search concepts, 
MeSH terms, exclusion and inclusion, data collection, and synthesis analysis.  
In achieving the research objectives, the following key concepts (see Appendix A) were 
used for literature searches: 1) Radiation-induced medical imaging (i.e., X-rays, dental X-rays, 
fluoroscopy, angiography, and computed tomography) are the exposures. 2) The target study 
population includes those up to 18 years of age. The following terms were to be used in the 
query: pediatrics, children, young age, and childhood. 3) Low- dose exposures were also 
included as a key concept as some of the procedures involved higher radiation doses. 4) 
Lastly, cancers are the health outcomes; the following types of cancer are of interest: all 
cancer types, solid cancer, tumour, or leukemia.  
PubMed and Scopus were the electronic databases used for the searches; other 
databases such as Cochrane, CINAHL and EMBASE have been intentionally omitted as this 
literature will have been included in the PubMed and/or Scopus databases. All four concepts 
were joined as one string for the databases (see Appendix A). The search syntaxes have been 
modified to fulfill the databases’ search requirements. The two search results were combined, 




Inclusion and Exclusion Criteria 
The inclusion and exclusion criteria were used for triage of the search literature. Tables 
6 and 7 provide a list of the inclusion and exclusion conditions. The key inclusion parameters 
are children, non-cancer patients prior to the first irradiation medical imaging procedure, low-
dose medical imaging exposures, patient-level cohort studies, and all cancer types health 
outcomes. The exclusion parameters include prenatal or adult patients, high-dose exposures, 




Table 6. Inclusion Criteria 
Categories Criteria Description 
 
Patient Age Newborn up to 18 years 
 
Sex Female and male 
 
Medical conditions No cancer, prior to first irradiation medical imaging 
procedure 
 
Modality Irradiation imaging 
procedures 
X-ray, dental X-ray, fluoroscopy, angiography, and 
computed tomography scan 
 
Exposed organs All body parts 
 





Cancer type All cancers, solid cancer, tumours, and/or leukemia 
 
Study design Patient-level health studies 
 
Observational studies (e.g., retrospective, 
prospective, case-control, cross-sectional,ecological, 
etc.) 
 
Exposure period All dates 
 







Date All documents, up to the date of document search 
(May 28th, 2018) 
 
Sources PubMed and Scopus 
 








Table 7. Exclusion Criteria 
Categories Criteria Description 
 
Patient Age Prenatal (pre-birth) or adults (age >19-year-old) 
 
Medical conditions Patients who developed cancers prior to radiation 
medical imaging 
 
Modality Imaging procedures Non-ionizing radiation (e.g., MRI, Ultrasound) 
 
Mammography procedures are typical administer in 
adult population (Radhakrishnan, 2017) 
 




Exposures Radiotherapy, occupational, environmental radiation 




Mathematical cancer risk studies 
Document Date None 
 
Language Non-English articles 
 






Data Collection  
From the selected articles, the following attributes/data have been gathered (see Table 8).  
Table 8. Journal Evaluation Criteria   
Categories Attribute Description 
 
Study Date of studies The study dates and ages of exposures are key 
factors for this investigation. The exposed doses 
may have been reduced over the years; thus, the 
results of the studies may have been affected 
 
Studies’ objectives The focus of the investigation 
 
Age of patients Ages of subjects for the studies from birth to 18 
years; grouped by birth to 1-year-old, 1 to 5-year-
old, 6 to 10-year-old, 11 to 15-year-old, and over 
16-year-old 
 
Cancer risks Record the cancer type, incidence rate and risks 
due to ionizing radiation exposure 
 
Modality Record the type of radiation medical imaging 
procedures that were used 
 
Dosages For the studies, observe the type of doses (e.g., 
absorb, equivalent, effective, or cumulative) that 
were applied 
 
Exposure frequency Observe the frequency of exposures for the 
studies 
 
Latency /Follow-up Record the latency, since the first exposure 
Data 
Analysis 
Study designs Identify the type of epidemiology study design of 
the studies 
 
Strengths/Limitations Observe the strengths and limitations of the 
investigations 
 
Risk calculations Identify the types of risks that were reported, such 
as Lifetime Attributable Risk, Relative Risk, Odds 




Categories Attribute Description 
 
Size of population Identify the studies population size 
 
Statistical method Observe the data analysis method, confidence 
level, and variances 
 











References Review the references that were used for the 
analysis, discussions, and conclusions 
 
Results Analyze the results present, the margin of errors, 
and statistical significance 
 
Conclusion statements Observe the conclusion statements, such as 
definitive and inconclusive 
 
 
Upon collecting the data (see Appendix B), the next steps were to organize and 
standardize the data into categories. Table 9 provides the information of interest for data 
analysis and synthesis. 
Table 9. Data Organization 
Categories Description 
 
Study timelines Group together the year of the cohort and the year of the studies 
 
Age Categorized by: 1) Less than 1-year-old, 2) 1 to 5-year-old, 3) 6 to 
10-year-old, 4) 11 to 15-year-old, and 5) 15 to 18-year-old 
 




If possible, categorize the dosages: 1) absorbed dose, 2) 
equivalent dose, 3) effective dose, and 4) cumulative dose 
 
If possible, categorize the exposed organs: 1) head, 2) chest, 3) 











Report on the evidence of all cancers, solid cancer, tumour, or 
leukemia based on the radiation-induced on the exposed organs. 






Reported on different levels of cancer risks, incidence rate, and 
ratios 
 
Risks & Incidence Rates: 
Lifetime Attributable Risk (LAR), Excess Lifetime Death (ELD), 
Excess Relative Risk (ERR), Excess Incidence Rate (EIR), 
 
Ratios: Relative Risk (RR), Odds Ratio (OR) Standardized Incidence 




Data Synthesis, Harmonization, and Reporting  
After data collection and organization of the data, the next steps were to perform data 
synthesis, evaluations, and comparisons. Table 10 provides a list of possible techniques and 
approaches that may be used for data synthesis and reporting.    
Table 10. Reporting Techniques 
Approaches Description Data Synthesis 
Classification Conversion/standardization of data 
• Exposure age groups (0-1, 1-5, 
6-10, 11-15, and 16-20) 
• Dosages (absorbed, equivalent, 
effective, and cumulative) 
• Expose organs (head, chest, 
abdomen and extremities) 
• Cancer risks 
• Convert and standardize the 
exposed age groups 
• Group the cohorts into age 
categories 
• Convert/translation risk 
nomenclatures into a standard 
risk indicator, if possible 
• Resolve data quality issues and 
remove outliers and non-
resolvable datasets, of possible 
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Approaches Description Data Synthesis 
• Align the data sets so that they 
present exposure, outcomes, 
and risks 
 
Comparative Data evaluations: 
• Modalities 
• Exposed age groups 
• Exposed gender 
• Exposed organs 
• Frequency of exposures 
Upon standardizing the data sets, 
the next steps were to use different 
statistical and epidemiological 
methods for calculations, 
comparisons, clustering, and 
associating, if applicable. The goals 
were to detect patterns, 
associations, and/or probabilities of 
the data sets 
 
Assessment Review of research methodologies: 
• Study design 
• Data collections 
• Bias and limitations 
• Results/conclusions 
• Narratives - key 
discoveries/outcomes 
 
Furthermore, each research report 
will be assessed for the quality of 
study design, data selection/ 
collection, bias, limitation, etc. 
Lastly, an overall assessment of the 
data collected will be conducted 
 
Reporting Cancer outcomes 
• Risks (positive, undetermined, 
negative) 
• Excess risks 
• Incidence rate (No. per 10,000 
or 100,000 persons) 
• Risk ratio 
 
As indicated in BEIR VII, the 
estimation of cancer risks can be 
expressed as an incidence 
rate/probability. Hence, the cancer 
risks in this research are to be 
harmonized as one of following 
risks: 1) probability of cancer 
development, 2) probability of 
developing cancer beyond the 
normal risks, 3) incidence cancer 





CHAPTER 5: FINDINGS 
Literature Search Results 
Four concepts (i.e., pediatrics, low dosage, irradiation diagnostic procedures, and 
cancer risks) were used for the literature search in the PubMed and Scopus databases. The 
details of the search terms and results were captured in (Appendix A). After conducting 
literature screening (see Figure 8), ten (10) articles were selected and two (2) manual search 
articles found to be eligible for this study. Of the twelve (12) eligible articles, there was one (1) 
for dental X-rays, three (3) for X-rays, zero (0) for fluoroscopy or angiography, and eight (8) for 
CT scans.  
 
Study Demographics 
As shown in Table 11, the twelve selected studies included in this review covered over 
one million patients cumulatively. The genders in most studies were evenly divided between 
females and males except for the study of dental X-ray exposure where the male to female 
ratio is 1:3 (Memon, 2010). CT scans studies provided the greatest number of participants. On 
population age, most of the diagnostic procedures performed were at ages zero to one and 
one to five years. Chodick noted that the use of diagnostic imaging reduced as the age of 
patients increased. He stipulated that this irregular CT scan usage pattern may be due to the 
greater cases of injuries and head trauma among those at the younger ages. With the increase 
in exposure, particularly higher doses of irradiation procedures such as CT scans, the lifetime 









Table 11. Study Populations 
 
  
Studies populations Ages of exposures 
No
. 










1 Memon et al., 
(2010) 
313 75 238 No 
data 
No data 6 51 
2 Inskip et al., 
(1995) 
484 113 371 No data 
3 Hammer et al., 
(2009) 
92,957 50,005 41,432 20,546 22,243 6,387 2,489 No data 
4 Hammer et al., 
(2011) 
78,527 42,436 34,829 No data 
5 Chodick et al., 
(2007) 
17,686 9,430 8,256 No data 
6 Pearce et al., 
(2012) 
178,604 leukemia 
176,587 brain tumors 
No data 
7 Mathews et al., 
(2013) 
680,211 357,119 323,092 42,798 N/A 104,618 202,420 330,375 
8 Miglioretti et 
al., (2013) 
744 372 372 No 
data 
232 219 293 No data 
9 Su et al., 
(2014) 
926 633 293 13 148 346 419 No data 
10 Huang et al., 
(2014) 
24,418 No data 
 
9,767 5,177 9,474 No data 
11 Niemann et al., 
(2015) 
522 291 231 110 201 130 73 No data 
12 Krille et al., 
(2015) 
44,584 26,146 18,387 16,496 12,929 15,159 No data 
 
 
Radiation Medical Diagnostics 
A. Dental X-rays  
 Dental X-rays are routine procedures that are used for the detection of teeth issues 
such as decay, cavities, bone loss, wisdom teeth, or abnormal bone structures. Often, these 
teeth issues are not vividly visible to the dental professionals. Therefore, most patients 
undertake dental X-rays every one or two years as part of their routine dental checkups. Due 
to the proximity of the thyroid gland, dental X-rays may impose thyroid cancer risks. The 
Atomic Bomb Survivor Life-Span Studies (LSS) indicated that the thyroid gland is a highly 
radiation-sensitive organ. Memon and colleagues suggested that there is a possible 
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association between dental X-rays and thyroid cancer. The case-control study consisted of 
patients aged 5 to 70 years with a sample size of 313; however, the children cohort size was 
n=57 (ages 5-14 (n=6) and 15-24 (n=51)). The overall study showed an Odds Ratio (OR) of 2.1 
(95% CI=1.4 – 3.1, and p-value of 0.001). The study also showed that 1-4 exposures had an OR 
of 2.2 (95% CI=1.4 – 3.5, p-value of 0.001), 5-9 exposures had an OR of 4.6 (95% CI=1.4 – 14.7, 
p-value of 0.01), and 10 or more exposures had an OR of 5.4 (95% CI=1.1 – 26.7, p-value of 
0.037). For gender-specific (females and males), the results showed an OR of 2.0 (95% CI=1.2 – 
3.3, p-value < 0.01) and 2.4 (95% CI=1.0 – 5.1, p-value of 0.05), respectively. This study did not 
disclose information on the exposed dosages (i.e., effective dose and cumulative dose). 
Overall, although the sample size was small (n=57), the study data showed an increasing risk 
associating dental X-rays with thyroid cancer, where the OR is significantly above the 
equilibrium point (OR=1.0). The study also indicated that there is an elevated risk with the 
increase of dental X-ray exposures. The data suggested that males and females are equally at 
risk. The study noted that protective lead collars were commonly used during the period of 
this dental X-ray study (1998-2002).  
 
B. X-rays 
 X-rays are common procedures used in detecting fractures and abnormalities of 
organs, tissues, and bones. Possible body regions include head and neck, chest and shoulders, 
spine and pelvis, upper and lower extremities, abdomen, and more. From LSS, human organs 
(such as red bone marrow, lungs, breasts, the thyroid, skin, and eyes) and children (including 
fetuses to ages 18 years) are highly susceptible to carcinogenesis. Due to the small sample 
size, further research is required.  
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Inskip and colleagues examined the risk of thyroid cancer from X-ray exposures to 
different parts of the body, during the period from 1980 to 1992. They conducted a case-
control study of 484 cases and 484 control subjects; females (n=371) and males (n=113,); and 
ages of <20 to >60. Overall, there were 2235 (female) and 682 (male) subject cases, and 2457 
(female) and 754 (male) control cases. For the group aged <20 years, there were 272 subject 
cases and 237 control cases. The results showed that with exposures of one to five times to 
the upper body regions (i.e., head, neck, and upper spine), the relative risk (RR) of developing 
thyroid cancer was 1.02 (95% CI= 0.76 -1.38). With exposures greater than six times to the 
same exposed body regions, the RR was 1.22 (95% CI= 0.46 – 3.34). Note, the doses applied to 
this region were indicated as the highest relative radiation dose to the thyroid gland in 
comparison to other exposed regions. Similarly, with one to five exposures to the upper-
middle body regions (i.e., chest, shoulders, and upper gastrointestinal tract), the RR was 1.06 
(95% CI= 0.78 -1.46). With exposures of six to ten times to the same body region, the RR was 
1.11 (95% CI= 0.67 - 1.87), and with exposures of >10 times, the RR was 0.99 (95% CI= 0.47 – 
2.08). Note, the doses applied to this region were indicated as the medium relative dose to 
the thyroid. Lastly, exposures of one to five times toward the lower middle body regions (i.e., 
abdomen, pelvis, and legs), the RR was 0.75 (95% CI=0.56 – 1.00), with exposures of six to ten 
times, the RR was 0.99 (95% CI= 0.60 - 1.62), and exposure of >10 times, the RR was 0.75 (95% 
CI= 0.42 – 1.35). Note, the doses applied to this region were indicated as the lowest relative 
dose to the thyroid. The effective doses range from 0.03 mGy (for small intestine) to 13 mGy 
(for thoracic spine). The study also investigated the risks of cumulative doses: 0.08 mSv, 0.32 
mSv, and 1.95 mSv, the relative risks were 1.05 (95% CI=0.73-1.52), 1.04 (95% CI=0.70-1.55) 
and 1.05 (95% CI=0.73-1.52), respectively. Based on the relative risks shown in this study 
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(ranges between 0.75 to 1.22), Inskip suggested the following: 1) there was no evidence 
linking thyroid cancer with X-rays, 2) there was no evidence that increasing the number of X-
ray exposures will elevate thyroid cancer risks, and 3) there was no evidence of elevated risks 
with the increase of cumulative doses. Due to the small pediatric study size, additional studies 
on this subject are required.   
Hammer and colleagues, published in 2009, investigated the childhood cancer risk 
from X-ray diagnostic imaging. This study comprised of 92, 957 children from a German 
hospital between 1976 – 2003. There were 50,005 boys and 41,432 girls, and their ages of 
exposure were less than 20 years. More than half of patients (59%) received only one 
examination, 19% and 8% received two and three procedures, respectively. Only 14% received 
four or more examinations. The Standardized Incidence Ratio (SIR) of all cancer risk was 0.99 
(95% CI=0.79 – 1.22), leukemia risk was 1.09 (95% CI=0.74 – 1.52), lymphoma risk was 0.97 
(95% CI=0.52 – 1.66), tumor (CNS) risk was 0.52 (95% CI=0.25 – 0.95), and other tumor risk 
was 1.25 (95% CI=0.85 – 1.77). The SIR on gender-specific was relatively equal; boys were 0.99 
(95% CI=0.74 – 1.29) and girls were 1.00 (95% CI=0.69 – 1.38). Similarly, the SIRs based on the 
number of X-ray examinations were relatively the same: one scan was 0.97 (95% CI=0.73 – 
1.27), two scans were 0.91 (95% CI=0.50 – 1.52), and three or more scans were 1.10 (95% 
CI=0.67 – 1.70). Furthermore, the Incidence Rate Ratio (IRR) on different exposed doses (0.0-
9.9 µSv, 10-49.9 µSv, and 50+ µSv) for all cancers were 1.00, 1.02, and 1.01, respectively. For 
leukemia and lymphoma, they were 1.00, 1.00, and 1.04, respectively while solid tumours 
were 1.00, 1.05, and 0.98, respectively. The SIR ranges from 0.97 to 1.25 which was close to 
1.0 and the results seem to suggest that there are no evaluated cancer incidence rates 
between the exposed and unexposed populations.       
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  Hammer and colleagues studied the childhood cancer risk from X-ray diagnostics. The 
cohort composed of 78,527 patients who received X-ray procedures from 1980 to 2006 where 
42,438 were boys, 34,829 were girls, and 1,263 were unknown. Most patients received only 
one examination (63%); the rest received two (19%), three (8%), and four or more 
examinations (11%). The median cumulative effective dose in all patients was 5 µSv. The SIR in 
all patients for all cancers risk was 0.97 (95% CI=0.75 – 1.23), solid tumors were 0.88 (95% 
CI=0.60 – 1.25), and leukemia and lymphoma were 1.05 (95% CI=0.74 – 1.45). The IRR in all 
patients with <10 µSv was 1.00 (reference point); 10-49.9 µSv was 1.08 (95% CI=0.62 – 1.90, 
p-value=0.78), and >=50 µSv was 1.05 (95% CI=0.56 – 1.98, p-value = 0.88). In both of Hammer 
and colleagues’ studies (2009 and 2011), the results also indicated that there was no evidence 
linking X-rays to cancer (i.e., all cancers, leukemia, lymphoma, or tumours). Likewise, there 
was no evidence linking multiple exposures or the increase of cumulative dose exposures to 
elevated cancer risks. 
The studies of X-rays (Inskip and Hammer) showed that the RRs are closely 1.0 which 
suggests that there is a very small cancer risk with normal X-ray procedures. The studies also 
showed that a single exposure has an RR<1.0 (e.g., RR=0.75 95% CI: 0.56-1.00) which 
hypothetically, may act as a cancer protection.  According to the BEIR hormesis model, a small 
radiation dose exposure may help to initiate the cell repair mechanisms, which subsequently, 






C. Fluoroscope and angiography 
The literature search did not find a patient-level study on fluoroscopy; however, there 
was a mathematical study on angiography and cancer risks of a 5-year-old child. Huang and 
colleagues, 2008, conducted on four retrospective ECG-gated CT coronary angiography 
protocols (40, 60, 70 and 90 bpm) in the United States and Hong Kong (China). The effective 
doses for the four protocols were 16.45, 12.17, 11.97, and 11.81 mSv. The results of the 
mathematical study indicated that the LAR of the 5-year-old boys and girls in the United 
States were 0.14% to 20% and 0.43% to 0.60%, respectively; and in Hong Kong were 0.22% to 
0.33% and 0.61% to 0.85%, respectively. Furthermore, Huang discovered that the risks were 
2.5-3.3 times higher in girls compared to boys, and Hong Kong children were 1.4-1.6 times 
higher than United States children.  The mathematical study, conducted in the United States 
and Hong Kong children, suggested that there were associations of angiography and cancer 
risks. 
        
D. CT Scans 
 CT scans provide cross-sectional images, or slices, of human organs, tissues, blood 
vessels, and bones. Similar to X-rays, they are used to detect bone fractures, diseases (organ 
diseases, disorders, or infections), blood clots, or cancer. Unlike X-rays, they emit high 
cumulative radiation doses to the examined organs to capture cross-sectional slices or images. 
The most common types of CT scans are brain, chest, abdomen or pelvis, spine, or neck. Due 
to higher radiation dose exposures, CT scans are considered high cancer risk procedures and 
they should only be prescribed if the medical benefits exceed the risks.  
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Chodick and colleagues studied cancer risks from CT scans in Israel between 1999 to 
2003. The cohort was comprised of 17, 686 children (males – 9,430 and females - 8,256), ages 
from birth to 18 years. The effective doses were 130 mGy (head CT) and 51 mGy (abdomen) at 
the age of < 3 years old; however, the effective doses reportedly decreased to 30 mGy (head 
CT) and 24 mGy (abdomen) as the ages of patients increased.  The final results showed that 
the excess lifetime death (ELD) for this study was 0.29%. The study reported that the ELD was 
higher in males than those of females (e.g., 0.78 vs. 0.48 for children ages <3, respectively). 
The investigator noted that a possible rationale for this result was that boys were more prone 
to head injuries and trauma than girls; and therefore, they required more CT scans. 
Ultimately, the excessive CT scans may lead to a higher excess in death rates.   
 Pearce and colleagues investigated the association of CT scans with leukemia and brain 
tumours. The cohort encompassed 178,604 leukemia and 176,587 tumour patients from the 
National Health Service (United Kingdom) during the period of 1985 to 2002. The 
administered effective doses (mGy) to the brain was (28 – 43 mGy), the chest was (0.2 - 0.4 
mGy), the abdomen was (0.0 –  0.2 mGy), and extremities was (0.0 mGy). In both cases, males 
and females had been prescribed similar effective dosages. The study noted that the 
prescribed effective doses were proportional to the children’s ages. The results showed that 
there was an associated risk of leukemia when CT scans are directly at the bone marrow. The 
excess relative risk (ERR) per mGy for leukemia was (0.042, p-value=0.6300) in females and 
(0.031, p-value=0.6300) in males; and for brain tumors was (0.016, p-value=0.0850) in females 
and (0.028, p-value=0.0850) in males. The data also showed that the increase in the number 
of CT scan procedures will lead to higher ERRs of leukemia (i.e., 1 CT scan, ERR of 0.013; 2-4 CT 
scans, ERR of 0.028; and >5 CT scan, ERR of 0.035; p-value of 0.8013) and higher ERRs of brain 
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tumors (i.e., 1 CT scan, ERR of 0.007; 2-4 CT scans, ERR of 0.021; and >5 CT scan, ERR of 0.018; 
p-value of 0.1213). Leukemia appears to be more prominent in the first few years after CT 
scan exposure; however, the ERRs decrease as the number of years since the exposure 
increases. The ERRs for Leukemia was 0.055 (2 to 5 years or less), 0.021 (5 to 10 years or less), 
0.005 (10 to 15 years or less) and 0.026 (15 years or more); p-value of 0.5357. The ERRs for 
brain tumours was 0.026 (5 to 10 years or less), 0.023 (10 to 15 years or less) and 0.005 (15 
years or more); p-value of 0.2399. In both cases, the younger the age when exposed, the 
higher leukemia and brain tumours cancer risks. Overall, this study showed how CT scans 
impose elevated risks of leukemia and brain tumour, more evidently in early ages of exposure 
and in repeated procedures. However, the risks seem to subside as the latency period since 
the first exposure increases.    
 Mathews and colleagues studied the relationship between CT scans and cancer 
incidence rates. This study consisted of 680,000 participants, ages of 0-19 years, who were 
born between 1985 and 2005. There were 357,119 (52.5%) males and 323,092 (47.5%) 
females. The percentages of CT scan procedures to the brain was 59.4%, facial bones were 
13.1%, extremities were 9.5%, the spine was 8.6%, the abdomen was 5%, the chest was 1.7%, 
and others was 2.7%. The overall incidence rate ratio (IRR) for 1-year, 5-year, and 10-year lag 
periods were 1.24 (95% CI=1.20 to 1.29), 1.21 (95% CI=1.16 to 1.26), and 1.18 (95% CI=1.11 to 
1.24), respectively. The absolute excess incidence rate (EIR) per 100,000 for all solid cancers, 
thyroid cancers, leukemia, and all cancers were 7.76 (95%, CI=6.24 to 9.27), 1.10 (95% CI=0.62 
to 1.59), 0.53 (95% CI=0.09 to 0.97), and 9.38 (95%, CI=7.68 to 11.08), respectively. 
Furthermore, the study showed that excess rate ratio per mSv of all cancers were 0.035 (95% 
CI=0.026 to 0.042) – 1-year lag period, 0.031 (0.022 to 0.040) – 5-year lag period, and 0.027 
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(95% CI=0.017 to 0.037) – 10-year leg period. Likewise, the excess rate ratio per mSv of brain 
cancer was 0.029 (95% CI=0.023 to 0.037) – 1-year lag period, 0.021 (0.014 to 0.029) – 5 years 
lag period, and 0.015 (95% CI=0.007 to 0.026) – 10 years leg period.  Similarly, the excess rate 
ratio per mSv of leukemia was 0.039 (95% CI=0.014 to 0.070) – 1-year lag period, 0.042 (0.010 
to 0.080) – 5 years lag period, and 0.017 (95% CI=0.029 to 0.078) – 10 years leg period. The 
study illustrated that there was an excess of cancer incidence comparing the exposed and 
unexposed groups. However, the incidence rate seems to reduce as the latency period of the 
first exposure increases.  
Miglioretti and colleagues studied the cancer risks from all CT scans. The cohort was 
comprised of six integrated healthcare systems in the United States. The data gathered was 
from 1996 to 2010, with 4,857,736 being child-years observed. The effective doses ranged 
from 0.03 to 60.2 mSv. Given that the ages of exposure were under five years, the lifetime 
attributable risk (LAR) per 10,000 of head CT scans was 17.5 for girls and LAR per 10,000 was 
7.4 for boys. The LAR for leukemia was 1.9 for both genders. For abdomen CT scans, girls had 
a LAR of 33.9 and boys had a LAR of 14.8 per 10,000 persons. As for leukemia, the LAR for 
both genders was 0.8. For chest CT scans, girls had a LAR of 28.4 and boys had a LAR of 8.4 per 
10,000 persons. The LAR for leukemia was 0.6 for both genders. Lastly, for spine scans, girls 
had a LAR of 37.7 and boys had a LAR of 5.3 per 10,000 persons. For leukemia risk, the LAR 
was 0.7 for both genders. However, the LARs of cancer were reduced when the patients’ ages 
increased (i.e., 5 to 9 years and ages 10 to 14 years). These declining trends apply to both boys 
and girls. The study seems to suggest that girls are more at risk compared to boys. Second, 
receiving CT scans at a younger age increases the LAR of cancer in both genders. Last, the 
incidence rate of solid cancer and leukemia reported increases as the number of CT scan 
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increases. For example (Miglioretti, 2013), the numbers of Head CT scans leading to 1 case of 
cancer were: ages <5 (570 CT scans), ages 5-9 (6,130 CT scans), and ages 10-14 (9,020 CT 
scans) in girls and ages <5 (1,350 CT scans), 5-9 (4,150 CT scans), and ages 10-14 (4,660 CT 
scans) in boys. The results showed similar patterns for abdomen, chest, and spine CT scans.                
Su and colleagues studied the thyroid cancer risk from CT scan procedures of 922 
children from China between January to December of 2012. The cohort comprised of 68% 
females and 32% males. The cohort ages were between 0 to 15 years. The CT scans in the 
study included paranasal sinus (10.4%), head (53.3%), chest (10.6%), abdomen/pelvis (18.5%), 
spine (3.1%), and extremities (4.1%). The applied doses to the sinus, head, and chest ranged 
from (0.61- 0.92 mGy), (1.10 -2.45 mGy), and (2.63 – 5.76 mGy), respectively. The results of 
this study showed that girls had a lifetime attributable risk (LAR) of thyroid cancer incidence 
per 100,000 children for sinus, head, and chest scans were 2.7 (95% CI=1.7-4.2), 8.7 (95% 
CI=2.8-48.5), 14.1 (95% CI=7.0-65.4), respectively. Moreover, the highest LARs for children 
aged less than one year was 23.6 (head scans) and 55.5 (chest scans) per 100,000 persons. As 
for boys, the LAR of sinus scans was 0.4 (95% CI=0.2-1.1), LAR of head scans was 1.1 (95% 
CI=0.4-3.6), and LAR of chest scans was 2.1 (95% CI=1.0-8.5) per 100,00 persons. Likewise, 
boys ages less than one year had LARs of 3.3 (head scans) and 7.8 (chest scans) per 100,000 
persons. The study suggested that chest CT scans imposed a higher LAR for developing thyroid 
cancer than CT scans of other parts of the body. Second, females seem to report a higher LAR 
relative to boys. Last, those children exposed at an early age exhibited a higher LAR of thyroid 
cancer than those who were exposed at later ages.  
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  Huang and colleagues studied the association of head CT scans with possible risks of 
malignancy and benign brain tumours. The cohort comprised of 24,418 patients between 
1998 to 2006. The median effective dose was 2 mSv for regular head CT examinations to 14 
mSv for stroke CT scan procedures. The study showed that for CT scan exposure, it had an 
overall Hazard Ratio (HR) of 1.29 (95% CI=0.90 – 1.85). Specifically, for a single CT scan 
exposure, the HR of brain tumours of malignant and benign, malignant, and benign were 2.56, 
1.84, and 2.97, respectively. The HR for leukemia was 1.90. The study also found that children 
who had CT scans at the ages of 4-5, the HR of brain tumours and malignancy were at the 
highest level. The appearances of cancer were seen in some children three years after the first 
CT scan procedure. Moreover, the HRs increase for every additional CT scan procedures.  
 Neimann and colleagues studied the lifetime attributable risk and mortality risk of a 
single chest CT scan on a cohort of 522 pediatric patients. The effective doses were: newborn 
(1.93 mSv), 5 years old (1.4 mSv), 10 years old (1.3 mSv), and 15 years old (0.85 mSv) 
respectively. The study indicated that there was be a positive association of CT chest scans 
with stomach, colon, liver, lung, breast, uterine, ovarian, bladder, thyroid, and leukemia 
cancers. For females, ages of zero to one, the LAR per 100,000 persons, for the cancers as 
indicated above, were 3.04, 1.34, 0.93, 28.72, 47.58, 0.07, 0.19, 26.22, and 2.05, respectively. 
For males ages, zero to one, the LAR of cancer, for the cancers as indicated above, were 2.73, 
2.56, 2.42, 14.36, 0.23, 5.76, and 3.07, respectively. Based on the results, they suggested that 
lung, breast, and thyroid cancers scored the highest LAR for both genders. As the ages of 
exposure increased, the LARs gradually decreased. These trends seem to apply to both boys 
and girls.   
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Krille and colleagues studied the risks of solid cancer, leukemia, and tumours from 
exposure to CT scans in children under the age of fifteen who were born between 1966 and 
2010. The study comprised of 44,584 patients (26,146 were boys, 18,387 were girls, and 51 
were unknown). However, the effective doses in this study were not provided. The results 
from this study showed that the Standardized Incidence Ratio (SIR) for all cancers, leukemia, 
lymphomas, CNS tumours, and solid cancer were 1.87 (95% CI=1.33-2.55), 1.72 (95% CI=0.89-
3.01), 3.26 (95% CI=1.63-5.83), 1.35 (95% CI=0.54-2.78), and 1.68 (95% CI=0.77-3.19), 
respectively. The study also showed that with the increase in the number of examinations 
(two or more), the SIRs also increase. For example, in all cancer for one CT scan, the SIR is 1.71 
(95% CI=1.12-2.25), and for two CT scans or more, the SIR is 2.29 (95% CI=1.22 to 3.91). These 
patterns were also shown for leukemia, lymphomas, CNS tumours, and solid cancers.        
 Overall, the studies of CT scans showed elevated incidences and risks of leukemia and cancers. 
These risks and incidences are dependent on exposed ages, exposed organs, repetitive procedures, 
and latency period. Sections below will address the cancer risks and incidence, and the dependant 
factors.  
   
Cancer Risks 
Linet and colleagues indicated that irradiation medical imaging dose in 2006 per capita 
in the United States was 3.0 mSv, compared to 0.53 mSv per capita in 1980. Secondly, as 
noted by Miglioretti, CT scan procedures had increased from 10 per 1000 children in 1996 to 
15 per 1000 children ages up to 5 years and 25 per 1000 children ages 5 to 14 years by 2015. 
Diagnostic medical imaging has been a valuable instrument for saving lives. The study seems 
to indicate that dental X-rays, X-rays, and CT scans impose moderate to high risks of thyroid 
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cancer, leukemia and lymphomas, tumours, solid cancer, and all cancers, and even cancer 
mortality. The trend of increasing irradiation diagnostic doses and frequent usages of medical 
imaging, especially on children, may provide reasons to be alarmed. Sections below will 
describe the findings in more detailed. 
 
A. Thyroid Cancer 
 Biomedical radiation studies such as BIER and LSS indicated that thyroid is one of the 
most common types of cancer in both children and adults; however, the biological sensitive 
reasons have yet been fully explained at this time. The results from this study indicated that 
dental X-rays, X-rays, and CT scans may have positive associations with thyroid cancer, 
particularly irradiation exposures near the thyroid gland region (Table 12). The incidence rate 
ratio, relative risk, and odds ratio, as shown in Table 12, above 1.0 indicated that there were 
elevated risks of thyroid cancer seen for Dental X-rays and CT scans. Also, the positive values 
of LAR indicated that there are probabilities of cancer risk. Due to the proximity of the thyroid 
in dental X-rays and due to higher doses prescribed in CT head scans, perhaps these may be 
causation for thyroid cancer. Memon indicated that the use of thyroid lead protective gear 
was not a common practice during the studied period between 1998-2002. Most dental X-ray 
protocols today required patients and dental practitioners to arm themselves with protective 
gears. Hopefully, this practice may help to protect the adverse effect of cancer risks. Thyroid 
cancer from chest X-rays to the abdomen and extremities regions appear to impose low risk; 
where RR is below 1.0 ratio. Moreover, X-rays to different body parts, such as head, chest, or 
abdomen, again demonstrated very low thyroid cancer risk (Hammer, 2009). The results of X-
rays studies showed that repetitive X-rays exposures, up to 10 procedures, do not seem to 
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elevate thyroid cancer risk. Furthermore, the latency of thyroid cancer development in various 
radiation diagnostics has not yet been clearly defined. Due to limited research that is available 
today; further studies are required in determining the potential risks.     
 
B. Leukemia and Lymphomas 
 Based on the literature of this research, leukemia and lymphomas may be associated 
with CT scan exposures (see Table 13). These cancer cells seem to illustrate a short latency 
period (Mathew, 2013 and Huang, 2014). A formation of cancer within the first five years after 
being exposed. Pearce suggested an excess relative risk (ERR) of 0.031 per mGy for males and 
0.042 per mGy for females. Furthermore, Miglioretti suggested that exposures to the 
abdomen compared to other body parts pose the highest risks (1 case per 10,000 scans), and 
the younger the ages of exposure, the higher the lifetime attributable risk (e.g., at age <5 
females, 33.9 per 10, 000 persons (Pearce, 2002). The cancer risks and medical benefits of CT 






Table 12. Thyroid Cancer Associations 
Study Modality Exposure Thyroid Cancer Risk Elevated Risk 
Mathews et al. 
(2013) 
CT scan Head IRR = 1.33 (95% CI=1.13 
- 1.57) 
Yes, since the IRR is above 
1.0 
Memon et al. 
(2010) 
Dental X-ray Dental OR = 2.10 Yes, since the OR is 
significantly above 1.0 
Inskip et al. 
(1995) 
X-ray Head RR = 1.00 to 1.22 Yes, since the RR is above 
1.0 
Su et al. (2014) CT scan Head Girls: LAR = 1.1 (95% 
CI=0.4 - 3.6) * 
Boys: LAR = 8.7 (95% 
CI=2.8 - 48.5) * 
Yes, since the LAR is a 
positive value 
Su et al. (2014) CT scan Sinus Girls: LAR = 2.7 (95% 
CI=1.7 – 4.2) * 
Boys: LAR = 0.4 (95% 
CI=0.2 – 1.1) * 
Yes, since the LAR is a 
positive value 
Mathews et al. 
(2013) 
CT scan Spine IRR = 1.78 (95% CI=1.24 
– 2.58) 
Yes, since the IRR is above 
1.0 
Inskip et al. 
(1995) 
X-ray Chest RR = 0.99 to 1.11 Yes, since the RR is above 
1.0. However, the risk may 
not be significantly high. 
Mathews et al. 
(2013) 
CT scan Chest IRR = 1.41 (95% CI=0.45 
– 4.38) 
Yes, since the IRR is above 
1.0 
Su et al. (2014) CT scan Chest Girls: LAR = 14.1 (95% 
CI=7.0 - 65.4) * 
Boys: LAR = 2.1 (95% 
CI=1.0 – 8.5) * 
Yes, since the LAR is a 
positive value 
Inskip et al. 
(1995) 
X-ray Abdomen RR = 0.75 to 1.10 Yes, since RR is above 1.0. 
However, the risk may not 
be significantly high. 
Mathews et al. 
(2013) 
CT scan Abdomen IRR = 1.47 (95% CI=0.83 
– 2.59) 
Yes, since the IRR is above 
1.0 
Mathews et al. 
(2013) 
CT scan Extremity IRR = 1.19 (95% CI=0.73 
– 1.94) 
Yes, since the IRR is above 
1.0. However, the risk may 
not be significantly high. 
 
IRR=incidence rate ratio, OR = odds ratio, RR = relative risk, LAR= lifetime attributable risk, 






Table 13. Leukemia and Lymphomas Associations 
Study Modality Exposure Leukemia and 
Lymphomas 
Elevated Risk 
Mathews et al. (2013) CT scan Head IRR = 1.16 (95% CI=0.99 - 
1.37) 
Yes, since the IRR is 
above 1.0.  
However, the risk 
may not be 
significantly high. 
Mathews et al. (2013) CT scan Spine IRR = 1.31 (95% CI=0.85 - 
2.04) 
Yes, since the IRR is 
above 1.0 
Miglioretti et al. (2013) CT scan Head LAR = 1.9 **, ages <5 
LAR = 0.9 **, ages 5-9 
LAR = 0.45 **, ages 10-14 
Yes, since the LAR is 
a positive value. 
Miglioretti et al. (2013) CT scan Spine LAR = 0.7 **, ages <5 
LAR = 0.4 **, ages 5-9 
LAR = 0.5 **, ages 10-14 
Yes, since the LAR is 
positive value. 
Mathews et al. (2013) CT scan Chest IRR = 0.74 (95% CI=0.18 - 
2.95) 
No, since the IRR is 
below 1.0 
Miglioretti et al. (2013) CT scan Chest LAR = 0.6 **, ages <5 
LAR = 0.5 **, ages 5-9 
LAR = 0.4 **, ages 10-14 
Yes, since the LAR is 
a positive value 
Mathews et al. (2013) CT scan Abdomen IRR = 3.24 (95% CI=2.17 – 
4.84) 
Yes, since the IRR is 
above 1.0 
Miglioretti et al. (2013) CT scan Abdomen LAR = 0.8 **, ages <5 
LAR = 0.5 **, ages 5-9 
LAR = 0.4 **, ages 10-14 
Yes, since the LAR is 
a positive value 
Mathews et al. (2013) CT scan Extremity IRR = 1.42 (95% CI=0.93 - 
2.16) 
Yes, since the IRR is 
above 1.0 
Hammer et al. (2009) X-ray All body IRR = 1.00 (reference) – 0 
cGy to IRR =1.05 (95% 
CI=0.73 – 1.52) with 1.95 
cGy cumulative exposure 
Yes, since the IRR is 
above 1.0. 
However, the risk 
may not be 
significantly high. 
Hammer et al. (2011) X-ray All body SIR = 1.04 (95% CI=0.51 – 
2.12) 
Yes, since the SIR is 
above 1.0. 
However, the risk 
may not be 
significantly high. 
Pearce et al. (2012) CT scan All body Male, ERR = 0.031 per 
mGy 
Female, ERR = 0.042 per 
mGy 
Yes, since the ERR is 
a positive value 
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Study Modality Exposure Leukemia and 
Lymphomas 
Elevated Risk 
Huang et al. (2014) CT scan All body HR =1.90 (95% CI=0.82 - 
4.40) * 
Yes, since the HR is 
above 1.0 
Krille et al. (2015) CT scan All body Leukemia 
SIR = 1.72 (95% CI=0.89 – 
3.01) 
Yes, since SIR is 
above 1.0 
Krille et al. (2015) CT scan All body Lymphomas 
SIR = 3.26 (95% CI=1.63 – 
5.83) 
Yes, since SIR is 
above 1.0 
Krille et al. (2015) CT scan All body CNS tumours 
SIR = 1.35 (95% CI=0.54 – 
2.78) 
Yes, since SIR is 
above 1.0 
Krille et al. (2015) CT scan All body Solid cancers 
SIR = 1.68 (95% CI=0.77 – 
3.19) 
Yes, since SIR is 
above 1.0 
 
IRR = incidence rate ratio, OR = odds ratio, RR = relative risk, LAR = lifetime attributable risk, SIR 
= Standardized Incidence Ratio, ERR = excess relative risk, HR = hazard ratio 




C. All Cancers 
 Benign and malignant tumours, solid cancer, and all cancers are considered as rare 
health diseases, especially in the children population. The studies showed that these risks may 
be closely associated with CT scans than with X-rays (see Table 14). For example, the data 
indicated that the excess relative risk was 0.016 per mGy for males and 0.028 per mGy for 
females (Mathews, 2013). The cancer latency studies (Matthew, 2013) indicated that the 
incidence rate ratios were 1.24 (95% CI=1.20-1.29, p<0.001)- 1-year lag period), 1.21 (95% 
CI=1.16-1.26, p<0.001) - 5-year lag period, and 1.18 (95% CI=1.11-1.24, p<0.001) - 10-year lag 
period. It has also been documented in BEIR and LSS studies that lag periods may extend to 15 
years after the first exposure. The complexity of studying the linkages of irradiation medical 
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imaging and solid cancers may be contributed to many factors: 1) cancer is considered as a 
rare disease in children, 2) cancer may have long latency periods, possibly 15 years period, 3) 
cancer risks are dependent on the exposed organs and exposed doses; and of equal 
importance, 4) cancer may be based on the patients’ genetically predisposed conditions, as 
well as medical conditions genetical, and/or lifestyles. One of the challenges is the long 
latency in cancer development, where the report of cancer incidents is not complete or 
accurate due to patients dropping out of the studies or lack to follow up. If the patients 




Table 14. Tumours, Solid Cancer, and All Cancers Associations 
Study Modality Exposure All Cancer Risk Elevated Risk 
Mathews et al. (2013) CT scan Head IRR = 1.23 (95% CI=1.18 – 1.29) Yes, since the 
IRR is above 1.0 
Miglioretti et al. (2013) CT scan Head Girls 
LAR = 17.5 **, ages <5 
LAR = 1.6 **, ages 5-9 
LAR = 1.1 **, ages 10-14 
 
Boys 
LAR = 7.4 **, ages <5 
LAR = 2.4 **, ages 5-9 
LAR = 2.1 **, ages 10-14 
Yes, since the 
LAR is a positive 
value 
Mathews et al. (2013) CT scan Chest IRR = 1.62 (95% CI=1.22 – 2.14) Yes, since the 
IRR is above 1.0 
Miglioretti et al. (2013) CT scan Chest Girls 
LAR = 28.4 **, ages <5 
LAR = 30.5 **, ages 5-9 
LAR = 20.9 **, ages 10-14 
 
Boys 
LAR = 8.4 **, ages <5 
LAR = 9.2 **, ages 5-9 
LAR = 6.1 **, ages 10-14 
Yes, since the 
LAR is positive 
value 
Niemann et al. (2015) CT scan Chest LAR of Cancer Incidence * 
Exposed age 0, males 
Stomach (2.73), Colon (2.56), 
Liver (2.42), Lung (14.36), and 
Bladder (0.23) 
 
Exposed age 0, females 
Stomach (3.04), Colon (1.34), 
Liver (0.93), Lung (28.72), Breast 
(47.58) and Bladder (0.19) 
 
 
LAR of Cancer Incidence * 
Exposed age 5, males 
Stomach (1.41), Colon (0.51), 
Liver (1.30), Lung (9.73), and 
Bladder (0.04) 
 
Exposed age 5, females 
Yes, since the 




Study Modality Exposure All Cancer Risk Elevated Risk 
Stomach (1.74), Colon (0.34), 
Liver (0.56), Lung (19.19), Breast 
(31.24) and Bladder (0.05) 
 
LAR of Cancer Incidence * 
Exposed age 15, males 
Stomach (.38), Colon (0.04), 
Liver (0.41), Lung (4.53), and 
Bladder (0.00) 
 
Exposed age 15, females 
Stomach (0.61), Colon (0.04), 
Liver (0.20), Lung (9.23), Breast 
(12.73) and Bladder (0.01) 
Mathews et al. (2013) CT scan Abdomen IRR = 1.45 (95% CI=1.10 – 1.92) Yes, since the 
IRR is above 1.0 
Mathews et al. (2013) CT scan Abdomen IRR = 1.61 (95% CI=1.38 – 1.88) Yes, since the 
IRR is above 1.0 
Miglioretti et al. (2013) CT scan Abdomen Girls 
LAR = 33.9 **, ages <5 
LAR = 25.8 **, ages 5-9 
LAR = 27.2 **, ages 10-14 
 
Boys 
LAR = 14.8 **, ages <5 
LAR = 13.7 **, ages 5-9 
LAR = 13.1 **, ages 10-14 
Yes, since the 
LAR is positive 
value 
Mathews et al. (2013) CT scan Extremity IRR = 1.36 (95% CI=1.11 – 1.67) Yes, since the 
IRR is above 1.0 
Mathews et al. (2013) CT scan Extremity IRR = 1.33 (95% CI=1.18 – 1.50) Yes, since the 
IRR is above 1.0 
Hammer et al. (2009) X-ray All body IRR = 1.00 (reference) – 0 cGy to 
IRR =1.05 (95% CI=0.73 - 1.52) 
with 1.95 cGy cumulative 
exposure 
Yes, since the 
IRR is above 1.0. 
However, the 
risk may not be 
significantly 
high. 
Hammer et al. (2011) X-ray All body SIR = 1.01 (95% CI=0.60 – 1.71) – 
all cancer 
SIR = 0.98 (95% CI=0.46 – 2.12) – 
solid tumors 
Yes, if the SIR is 
above 1.0. 
However, the 
risk may not be 
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Study Modality Exposure All Cancer Risk Elevated Risk 
significantly 
high. 
Pearce et al. (2012) CT scan All body Male, ERR = 0.016 per mGy 
Female, ERR = 0.028 per mGy 
Yes, since the 
ERR is a positive 
value 
Huang et al. (2014) CT scan All body HR =2.56 * (95% CI=1.44 – 4.54) Yes, since the HR 
is a 
positive value 
Huang et al. (2014) CT scan All body HR =0.65 * (95% CI=0.35 - 1.19) Yes, since the HR 
is a 
positive value 
Huang et al. (2014) CT scan All body HR =1.29 * (95% CI=0.90 – 1.85) Yes, since the HR 
is a positive 
value 
Krille et al. (2015) CT scan All body SIR = 1.87 (95% CI=1.33 – 2.55) Yes, since the HR 
is a positive 
value 
 
IRR = incidence rate ratio, OR = odds ratio, RR = relative risk, LAR = lifetime attributable risk, SIR = 
Standardized Incidence Ratio, ERR = excess relative risk, HR = hazard ratio 





D. Cancer Mortality 
 Chodick and colleagues studied the cancer excess lifetime death (ELD). This study 
suggested that the overall patient lifetime excess death was 0.29% and that children aged less 
than three years have the highest mortality rate (0.52%). The ELD showed a trend of decline 
as the patients’ age increased. Males’ excessive cancer death from head CT scans appear to 
be higher than females at 55% and 38%, respectively. The study also noted that most medical 
examinations were due to forehead trauma, particularly in boys. It is possible that due to the 
patients’ medical conditions and circumstances, there was an elevated need for frequent CT 
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scans. It is possible that head trauma may be a confounding factor in the excess cancer death 
rate in boys. More studies are needed on this specific subject.  
 Niemann also indicated that a chest CT scan may result in LAR of cancer incidence, 
mortality per 100,000 persons, of thyroid (1.8), stomach (0.45), lung (0.45), and breast (0.39). 
Furthermore, females have a mortal risk of 0.31, compared to males of 0.16 per 100, 000 
persons. However, the risks appear to decrease as the children’s ages increase.  
 A few findings in this study seem to align with BEIR reports: 1) In a few studies, they 
showed girls are more radiosensitive than boys (see Appendix B, Table 19); however, the 
trends may be reversed in adulthood. The reasons for such changes may be due to 
environmental factors, occupational hazards, and/or differences in lifestyle (Dorak, 2102), 2) 
exposure to irradiation at early ages seemed to increase the lifetime cancer risks for both 
genders (Chodick, 2012, Miglioretti, 2013, Su, 2002, and Huang, 2014), 3) the frequent 
exposures tended to increase the lifetime cancer risks (Memon, 2010; Pearce, 2012; and 
Huang 2014), and 4) higher administered radiation doses seemed to increase the likelihood of 
cancer risks (Chodick, 2012). This study also suggested that radiation exposure to the thyroid 
gland, lungs, and bone marrow are most likely to increase the cancer risk, possibly due to 
higher radiosensitivity in organs. However, this study reported that X-rays procedures to all 
body parts and repetitive exposures, up to ten occurrences, have not shown evaluated cancer 
risks. Due to limited studies available today on X-rays, this subject requires further 
investigation. Last, although only one study is available today and the studied population 
comprised of a very small sample size, Memon suggested that dental X-rays are highly 
correlated with thyroid cancer.  
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 Appendix B provides a series of tables which map the exposures, outcomes, and risk 
levels. These tables show that dental X-rays are highly associated with thyroid cancer, 
whereas general X-rays are less associated with thyroid, leukemia, or solid cancer. CT scans, 
however, are prone to cancer and cancer mortality risks.   
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CHAPTER 6: DISCUSSION 
Prior radiation exposure intelligence 
Much of radiation carcinogenesis intelligence had been gathered from BEIR III (1980), 
V (1990), and VII (Phase 1 - 1998 and Phase 2 - 2006) reports. BEIR VII suggested that “one 
individual in 100 persons would be expected to develop cancer (solid cancer or leukemia) 
from a dose of 100 mSv”. The research further indicated that the excess cases from 100 mSv 
exposures yielded 800 male and 1300 female cases of all solid cancer per 100,000 persons. 
Likewise, for 100 mSv irradiation exposure, it resulted in 100 male and 70 female cases of 
leukemia per 100,000 persons. From the patient demographic perspective, the studies 
suggested that children (of all genders) were more radiosensitive than adults and that females 
were more radiosensitive than males. As for exposures, for every additional radiation 
exposure, the lifetime cancer risk would also elevate. Furthermore, the earlier the ages of 
exposure, independent of gender, the lifetime cancer risk would also be elevated. With the 
increase in exposed irradiation dosages (i.e., absorbed, equivalent, effective, or cumulative 
dosages), the lifetime cancer risk would also increase. In most cases, the lifetime cancer risks 
exhibit a linear no-threshold risk pattern; however, there were possible cases of hormesis. 
Furthermore, in some cases, cancer development may have a long latency period, possibly be 
extended to five, ten, or fifteen years. It appears that lymphoid, bone marrow, blood, lung, 
thyroid, breast, skin, and eyes are considered relatively higher radiosensitive organs (Rubin 
and Casarett, 1968), the reasons for this radiosensitivity remained unclear at this point. It is 
important to note that the datasets for these studies were based primarily on the atomic 
bomb, radon, and nuclear accident cohorts, and not from irradiation medical imaging. The 
question is, then, how do the data from the BEIR reports corollate with this research? 
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Research Gaps  
 The scoping review showed that there are limited studies on patient-level health for 
modalities such as dental x-rays, x-rays, and CT scans. The results indicated that there are 
elevated cancer risks associated with CT scans for thyroid and leukemia cancers, and high risk 
associated with dental X-rays and thyroid cancer. Due to the limited data available, the 
review’s results cannot be simply declared as conclusive at this time. As mentioned earlier, 
there are several factors contributing to the elevated risks. The scoping review unveiled 
several literature gaps. As illustrated in Appendix B, Table 17, the data points from the studies 
are quite diverse and are measured in different risk measurement units. In addition, there is 
only one study on dental X-rays, three studies on X-rays, and eight studies on CT scans. 
Furthermore, although there are eight studies on CT scans, the studied topics and objectives 
are quite different from each other. It would not be feasible to perform quantitative or meta-
analysis at this time. It should be noted that there are no patient studies on fluoroscopy or 
angiography imaging in children. However, there is a mathematical study on angiography 
based on a 5-year-old patient phantom analysis (Huang, 2008). Huang indicated that with an 
effective dose of ranging from 11.81 mSv to 16.46 mSv, the mathematical model shows a LAR 
of 0.14% to 0.20% (boys) and 0.43% to 0.60% (girls) in the United States and 0.22% to 0.33% 
(boys) and 0.61% to 0.85% (girls) in Hong Kong. Fluoroscopy and angiography modalities 
typically emit greater radiation doses than those of x-rays (e.g., 0.025 mSv per procedure). 
Due to higher exposed doses, this indeed highlights the urgent need for research on patient 
health studies. Secondly, the scoping review did not find studies that address the cancer risks 
on cumulative dose exposures. The cancer risk on cumulative exposure may be different 
depending on the length of time between the exposures (i.e., 3 exposures within a year or 1 
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exposure per year for 3 years). Based on the stochastic principle, some cancers may not be 
truly identifiable until the child patients become adults. Su, Pearce, and Huang suggested that 
early ages of exposures lead to higher lifetime cancer risk based on the LSS risk models. On 
the contrary, Mathews’ study indicated that ERR and IRR for all cancers and tumours will 
decline as the latency period increase since 1, 5, and 10 years after the first exposure. Based 
on the literature gathered, there are no longitudinal studies on radiation exposure and cancer. 
Although the research offered good insight into radiation medical imaging and cancer risk in 
children, much research is required.                 
 
Patient-Level Risks 
On patient cancer risks, Huang (2014) highlighted that a young child of ages 0 to 6 
scored the highest cancer hazard risk (HR=1.96 per 100, 000 persons); however, the hazard 
risks seemed to gradually decrease as the ages of exposure increase (HR=0.93 per 100, 000 
persons at ages 7 to 13). This finding has been confirmed by other studies (Su, 2002; Chodick, 
2012; Pearce, 2012; Niemann, 2015; and Miglioretti, 2013) that the lifetime risks, incidence 
rates, and risks ratio were reduced as the ages increase; the lowest risks of exposure were the 
adolescent ages (see Appendix B, Table 17). Due to rapid growth in younger children, the 
possibility of illegitimately rejoining of the chromosomes may cause DNA mutations; hence, 
may elevate the risk of cancer. As indicated in Matthews, the latency period may extend to 
15-years and beyond. For this reason, the recommendations are to limit the amount of 
radiation medical imaging procedures in younger children; and if these procedures are 
necessary, the exposed doses should be as low as possible.       
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On gender differences and cancer risks, are females more radiosensitive than males? 
The results from most studies offered different results between genders (see Appendix B, 
Table 19). Huang (2014) indicated that males (HR=1.29 per 100,000 persons) may be at a 
slightly higher risk than females (HR=1.28 per 100,000 persons). Although the delta seems to 
be marginal which suggested the possibility of no gender differences. In other studies, Su, 
Chodick, and Niemann showed that the ERRs and LARs of CT Scans between genders were 
drastically different. For example, the ERR per mGy for females of 0.042 versus males of 0.031 
and LARs of 2.7 (females) and 0.4 (males) per 100,000 persons. Based on these comparisons, 
the results showed that there is a gender cancer susceptibility difference. As mentioned in the 
earlier chapter, Dorak and Karpuzoglu studied the physiological variations and cancer 
susceptibilities in the gender. This study suggested that the susceptibilities may change as the 
children became adults. However, there are no studies that have been conducted on gender 
differences and cancer susceptibility for children and following into adulthood. This could be a 
valuable topic for future studies. 
Overall, the findings on patient-level risk seem to match the BEIR report on age and 
cancer risk. Children, at early ages of exposure, exhibit a higher lifetime cancer risk 
independent of gender. Due to the children’s ongoing cell development, the risks of DNA 
mutations from radiation are greater in younger children. As for gender differences, the 
results showed that females were more vulnerable in CT Scans. However, there are no 




Contributing Risk Factors 
The research showed that elevated cancer risk may be attributed to the following 
factors: age at exposure, the frequency of exposures, and the latency period of cancer 
development. The research found that the age of exposure as one of the key factors for 
elevated cancer risk. The studies suggested that children at ages less than 1-year-old is 
grouped with the highest LAR (Miglioretti, 2013). Furthermore, the LAR seems to decline as 
the ages of exposure increased. Younger children are anticipated to have a longer number of 
years to live; therefore, they have been predicted to have more chance of developing cancer. 
This risk model has been based on the LSS; based on the literature gathered, there are not 
radiation medical imaging longitudinal studies that have been conducted. Further studies are 
required to confirm such results.          
On the frequency of exposures, Pearce showed the ERR per mGy of developing 
leukemia on 1 CT scan is 0.013, 2 to 4 CT scans is 0.028, and 5 or more CT scan is 0.035. 
Likewise, Huang (2014) showed an overall cancer Hazard Risk of 1.21 per 100, 000 persons for 
one CT procedure, 1.68 for two CT procedures, and 5.04 for three or more CT procedures. 
Memon also showed that for one to four dental X-ray exposures, he reported one to four 
exposures had an OR=2.2, five to nine exposures had an OR=4.6, and ten or more exposures 
had an OR=5.4. For X-rays, the SIR of one exposure was 0.97, SIR of two exposures was 0.91, 
and SIR of three or more exposures was 1.10 in Hammer. Currently, there are no longitudinal 
studies that follow the pediatric patients into adulthood. With the increase in the number of 




Although the cancer risk for X-rays is low, the SIRs also increase as the number of 
exposures increase. Hammer (2009) was the only study that captured the cumulative exposed 
doses and the relative risk of developing cancer. It showed that a cumulative dose of 0 µSv to 
9.9 µSv has a relative risk (RR) of 1.00, 10 µSv to 49.9 µSv has an RR of 1.02, and 50+ µSv has 
an RR of 1.01. According to the data, additional exposures, although the changes are quite 
small, they do suggest an elevated risk. 
On latency effect, Matthews and Huang indicated that in some cancers, the cancer 
development may have long latency periods, extending to five years (IRR=1.21), ten years 
(IRR=1.18), and possibly beyond. Notably, some cancers (e.g., Brain) seems to be elevated in 
the fourth and fifth years and then decline thereafter (Huang, 2014). Contrary to the theory of 
LAR, cancer risks may possibly decline as the years since first exposure increase. Therefore, 
the development of cancers may be elevated due to other factors and not solely on radiation 
medical imaging (Dorak, 2012). Again, there are no radiation medical imaging longitudinal 
studies that have been performed on this subject; the risks were based on LSS studies. The 
risk factors found in this research seem to be consistent with the BEIR VII report.  
 
Modalities and Cancers Association 
Memon, Su and Matthews suggested that dental x-ray (OR=2.10) and CT scans (LAR = 
2.1 and IRR=1.78) may induce thyroid cancer. Due to the proximity of the thyroid gland and 
the examined region, this may result in thyroid cancer risks. Another possible theory is that 
the thyroid gland is more radiosensitive in children than anticipated. At this point, there is 
insufficient data to draw a conclusion.  
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American Childhood Cancer Organization, published on their website, suggested that 
acute lymphoblast leukemia ranked first in childhood cancer (26% percent rate). Pearce, 
Matthews, and Miglioretti found that CT scans may induce leukemia (as demonstrated by 
ERR= 0.031 per mGy, IRR=3.24, and LAR= 0.7 per 100,000 persons). As Rubin and Casarett 
indicated, bone marrow is found to be one of the most radiosensitive organs. Due to the 
highly radiosensitive nature, leukemia can be fully developed within the first five years of 
exposure. Therefore, leukemia is highly associated with CT Scan in children.  
Huang showed that angiography (mathematical study) may impose cancer risk in 
children. The research has indicated that there could be significant risks with this modality. 
This modality typically emits higher radiation doses than those of X-ray procedures as 
indicated in Huang (16.45, 12.17, 11.97, and 11.81 mSv). At this point, there are no patient-
level studies that have been performed. Further studies on patient-level may offer better 
insight of the cancer risks.      
Inskip and Hammer suggested that at minimal X-ray exposures, they do not seem to 
impose cancer risks (RR<1.0). However, increase exposures up to ten occurrences seem to 
elevate the cancer risks. It is unclear as to which types of cancer may be developed. Based on 
the three studies, the cancer risks appeared to be marginal. It is possible that the exposure 
doses and exposure organs were considered as low radiosensitivity. Due to the limited 
research at this point, it would be challenging to conclude the cancer risks. More studies are 
required to better understand the true health impact of X-rays. Prospective longitudinal 




CHAPTER 7: STRENGTHS AND LIMITATIONS  
The strengths of this research included repeatable methodology, data collection 
strategy, and peer reviews. This research utilized a standard scoping review methodology and 
the results were carefully screened for eligibility. The data were then categorized, 
summarized, and compared with similar studies. The study utilized the knowledge and results 
of radiation health studies in the last decade (BEIR and LSS). Last, the search strategy and 
results have been peer-reviewed by associate graduate students and library specialists. The 
limitations of this research included search strategy limitations, screening and evaluation 





CHAPTER 8: CONCLUSION 
The results from this scoping review indicate that there is possible cancer association 
with radiation medical imaging in children. This study suggested that there is a possible strong 
association between dental X-rays and thyroid cancers. The study also suggested a possible 
link between leukemia and CT scans. The study found that X-rays were considered low-risk 
when prescribed under normal conditions. Although the results suggested possible risks, 
however, due to the small sample data, it is not possible to reach more conclusive statements 
at this time. Furthermore, the scoping review found several research gaps: 1) the review did 
not find patient-level studies on fluoroscopy or angiography, 2) dental X-ray is linked to 
evaluated thyroid cancer; however, the studied children population was relatively small, 3) 
due to stochastic cancer risk of low dose exposures, based on the literature gathered, there 
are no studies that follow-up the child patients into adulthood, and 4) there are no studies 
that address the cancer risks on cumulative dose exposures.  
Today, medical diagnostic imaging health professional and patients are more aware 
and better educated on the risks and benefits of radiation diagnostic procedures. However, 
there are gaps in understanding the differences in gender, organs radiosensitivity, and long-
term cancer effects. As precautions, many dental x-rays required patients to wear chest and 
neck lead vest. In addition, many organizations such as the World Health Organization and 
Canada Safe Imaging have established to provide guidelines, tools, and education on patient 
radiation safety. As a general recommendation on patient radiation safety, many practitioners 
follow the radiation practice principle known as “As-Low-As-Reasonably-Achievable (ALARA)” 
while balancing the risk of misdiagnosis. Due to the limited radiation medical imaging studies 
in children that are available today, more studies are much needed. As for suggestions for 
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future research, more investigation is needed on cancer risks associated with dental x-rays 
and angiography as insufficient evidence are shown in the current studies. In addition, the 
current lifetime attributable risk is based on Life-Span Study (LSS), and retrospective 
longitudinal studies may help to validate the lifetime cancer risk in children. The LSS, BEIR and 
this research found that exposure to radiation elevates the lifetime risk. Therefore, it is 
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APPENDIX A – SEARCH CONCEPTS/TERMS & RESULTS 
Table 15. Appendix A - Literature Search Terms & Results   
 Concepts / Mesh Terms 
1 Population: (paediatric* OR pediatric* OR children OR child* OR childhood OR young-age OR juvenile OR youth* OR adolescent* 
OR toddler* OR post-natal) 
 
2 Exposure: ("low-dose ionising radiation" OR low-dose OR radiation-induced OR Low-LET OR low-level OR "radiation effect") 
 
3 Modality: ("diagnostic imaging" OR X-ray* OR "dental X-ray" OR "CT Scan" OR "computed tomography" OR fluoroscopy OR 
radiography) 
 
4 Cancer risk: (cancer* OR neoplasm* OR "solid cancer" OR "all cancers" OR leukemia OR leukaemia OR "thyroid cancer" OR 






User Query Count 
PubMed Best matches for (("paediatric"[All Fields] OR "pediatric"[All Fields] OR "children"[All Fields] OR 
"child"[All Fields] OR "childhood"[All Fields] OR "young-age"[All Fields] OR "juvenile"[All Fields] OR 
"youth"[All Fields] OR "adolescent"[All Fields] OR "toddler"[All Fields] OR "post-natal"[All Fields]) AND 
("low-dose ionising radiation"[All Fields] OR "low-dose"[All Fields] OR "radiation-induced"[All Fields] OR 
"Low-LET"[All Fields] OR "low-level"[All Fields] OR "radiation effect"[All Fields]) AND ("diagnostic 
imaging"[All Fields] OR "X-ray"[All Fields] OR "dental X-ray"[All Fields] OR "CT Scan"[All Fields] OR 
"computed tomography"[All Fields] OR "fluoroscopy"[All Fields] OR "angiography"[All Fields] OR 
"radiography"[All Fields]) AND ("cancer"[All Fields] OR "neoplasm"[All Fields] OR "solid cancer"[All 






User Query Count 
Fields] OR "tumors"[All Fields] OR "lesions"[All Fields] OR "benign"[All Fields] OR "malignant" OR 
"cancer mortality"[All Fields])) 
 
Search performed on May 28, 2018 
 
Scopus ( TITLE-ABS-KEY ( ( paediatric*  OR  pediatric*  OR  children  OR  child*  OR  childhood  OR  young-age  
OR  juvenile  OR  youth*  OR  adolescent*  OR  toddler*  OR  post-natal ) )  AND  TITLE-ABS-KEY ( ( "low-
dose ionising radiation"  OR  low-dose  OR  radiation-induced  OR  low-let  OR  low-level  OR  "radiation 
effect" ) )  AND  TITLE-ABS-KEY ( ( "diagnostic imaging"  OR  X-ray*  OR  "dental X-ray"  OR  "CT Scan*"  
OR  "computed tomography"  OR  fluoroscopy  OR  radiography ) )  AND  TITLE-ABS-KEY ( ( cancer*  OR  
neoplasm*  OR  "solid cancer"  OR  "all cancers"  OR  leukemia  OR  leukaemia  OR  "thyroid cancer"  OR  
tumor*  OR  lesion*  OR  benign*  OR  malignant*  OR  "cancer mortality" ) ) ) 
 






    
 
 
Table 16. Appendix A - Studies Selection 
Title, Author, and Year Study Design 
& Period 







1. Dental X-rays 
Dental X-rays and the risk of thyroid cancer: a case 
control study 
 




1998 to 2002 
N=313 ages 5 to 70 
 
 
Head Thyroid cancer Odds Ratio 
77 
 
Title, Author, and Year Study Design 
& Period 








Medical Diagnostic X rays and Thyroid Cancer 
 




Jan 1, 1980 to 
Dec 31, 1992 
N=484 <20, 20-39, 
40-59, >=60 
Lungs, chest, 
ribs, head, all 
types 
Thyroid cancer Relative 
Risk 
3. X-ray 
A cohort study of childhood cancer incidence after 
postnatal diagnostic X-ray exposure 
 





N=92,957 from 6 
months old 
to less than 
14.5 years 
old 







Childhood Cancer Risk from Conventional 
Radiographic Examinations for Selected Referral 
Criteria: Results from a Large Cohort Study 
 





N=78,527 from 6 
months old 
to less than 
14.5 years 
old 







5. CT Scan 
Excess lifetime cancer mortality risk attributable to 
radiation exposure from computed tomography 
examinations in children 
 





N=17,686 <=3 to 18 
years of age 








6. CT Scan 
Radiation exposure from CT Scans in childhood and 
subsequent risk of leukemia and brain tumors: a 
retrospective cohort study 
 




Jan 1, 1985 - 
Dec 31, 2008 



















Title, Author, and Year Study Design 
& Period 







7. CT Scan 
Cancer risk in 680,000 people exposed to CT Scan in 
childhood or adolescence: data linkage study of 11 
million Australians 
 




Jan 1, 1985 - 
Dec 31, 2005 







All cancers Incidence 
Rate Ratio 
8. CT Scan 
The use of Computed Tomography in Pediatrics and 
the associated radiation exposure and estimated 
cancer risk 
 




















9. CT Scan 
Radiation Dose in the Thyroid and the Thyroid 
Cancer Risk Attributable to CT Scans for Pediatric 
Patients in One General Hospital of China 
 




Jan 1, 2012 to 
Dec 31, 2012 




and chest CT 
Scans 
Thyroid Thyroid cancer Lifetime 
Attributable 
Risk 
10. CT Scan 
Paediatric head CT Scan and subsequent risk of 
malignancy and benign brain tumor: a nation-wide 
population-based cohort study 
 
W-Y Huang et al., 2014, Taiwan 
Case Control 
 
Jan 1996 – 
Dec 2008 
N=24,418 under 18 











11. CT Scan 
Estimated risk of radiation-induced cancer from 
paediatric chest CT: two-year cohort study 
 





N=522 under 18 
years of age 
Helical chest 
CT 





Title, Author, and Year Study Design 
& Period 







12. CT Scan 
Risk of cancer incidence before the age of 15 years 
after exposure to ionizing radiation from CT: results 
from a German cohort study 
 
Lucian Krille et al., 2015, Germany 
Case control 
 
Jan 1, 1980 -
Dec 31, 2010 














APPENDIX B –  STUDIED DATA 
Table 17. Appendix B - Exposures and Outcomes   











Solid Cancer Leukemia Thyroid Mortality 
1 Memon 
et al. 













Cat 1 (0.00 
mGy) 
 
Cat 2 (0.08 
mGy) 
 
Cat 3 (0.32 
mGy) 
 
Gat 4 (1.95 
mGy) 




risk), RR = 








risk), RR = 







risk), RR = 

































IRR = 0.98 to 
1.05 






effective dose = 














































1.81 to 2.61 
 
Rest of 















Solid Cancer Leukemia Thyroid Mortality 
lifetime 
death = 






Brain = 28 to 44 
mGy 
 
Chest = 2 to 4 
mGy 
 
Abdomen = 1 to 
2 mGy 
 











N/A Brain tumors:  
Male ERR per 
mGy = 0.016 
 
Female ERR 
per mGy = 
0.028 
Male ERR per 
mGy = 0.031 
 
Female ERR 








year lag (40 
mGy), 10 years 
lag (40 mGy), 15 




year lag (4.6 
mGy), 10 years 
lag (4.7 mGy), 












EIR = 7.76 per 
100,000 
EIR = 0.53 per 
100,000 





ti et al. 
Effective doses: 
 




















Solid Cancer Leukemia Thyroid Mortality 
Ages (<5) mean 
dose = 10.6 mSv 
 
Ages (>=5) 






































Age <5= 0.8; 
Age5-9=0.7; 
Age10-14=1.0 
10 Su et al. Absorbed doses: 
Head = 1.10 - 
2.45 mGy;  
 
Chest = 2.62 - 
5.76 mGy;  
 
Other = 0.61 - 
0.92 mGy 
696 139 242 230 N/A N/A N/A LAR of 
incidence: 
Sinus CT 






















Solid Cancer Leukemia Thyroid Mortality 
Head CT 


































N/A N/A N/A N/A N/A HR = 
1.29 per 
100,000 
HR = 1.84 to 
2.97 per 
100,000 
















Solid Cancer Leukemia Thyroid Mortality 
12 Nieman






5 years = 1.4 
mSv, 
 
10 years = 1.3 
mSv, 
 




N/A N/A N/A No data No data - 
Breasts and 
lungs 




28 to 2.05; 
Colon:0.01 






to 14.54;  
 
Breasts:5.3
5 to 11.13; 
 
Uterus:0.0 
to 0.02;  
 
Ovaries:0.0




0 to 0.05;  
 
Leukemia:0
.31 to 0.92 
12 Krille et 
al. 
No data 29,281 4,110 1,956 10,000 SIR = 
1.71 






Table 18. Appendix B - Studied Results Summary 
No. Modality Author Exposure 
 
Outcome Result Elevated Risk 




2 X-rays Inskip et al. (1995) Head Thyroid RR = 1.00 (reference) 
– no exposure to 1.22, 




3 X-rays Inskip et al. (1995) Chest Thyroid RR = 1.00 (reference) 
– no exposure to 0.99, 
95% CI: 0.47- 2.08 - 6 
exposures 
No 
4 X-rays Inskip et al. (1995) Abdomen Thyroid RR = 1.00 (reference) 
– no exposure to 0.75, 




5 X-rays Hammer et al. (2009) All body All Cancer IRR = 1.00 (reference) 




6 X-rays Hammer et al. (2009) All body Leukemia and 
lymphoma 
IRR = 1.00 (reference) 




7 X-rays Hammer et al. (2009) All body Solid tumors IRR = 1.00 reference 








9 X-rays Hammer et al. (2011) All body Leukemia and 
lymphoma 





No. Modality Author Exposure 
 
Outcome Result Elevated Risk 
 




11 CT Scan Chodick et al. (2007) Head Mortality ELD (boys) = 0.78 to 
2.61; ELD (girls) = 
0.48 to 1.81 
 
Yes 
12 CT Scan Chodick et al. (2007) Rest of body Mortality ELD (boys) = 0.13 to 
2.18; ELD (girls) = 
0.33 to 2.90 
 
Yes 
13 CT Scan Pearce et al. (2012) Brain, Chest, Abdomen, 
and Extremity 
Leukemia ERR = 0.031 (male) 
per mGy and 0.042 
(female) per mGy 
 
Yes 
14 CT Scan Pearce et al. (2012) Brain, Chest, Abdomen, 
and Extremity 
Brain tumors ERR = 0.016 (male) 
per mGy and 0.028 
(female) per mGy 
 
Yes 






















No. Modality Author Exposure 
 
Outcome Result Elevated Risk 

















































No. Modality Author Exposure 
 
Outcome Result Elevated Risk 
 














































No. Modality Author Exposure 
 
Outcome Result Elevated Risk 
43 CT Scan Su et al. (2014) Sinus Thyroid LAR (girls)= 2.7, 95% 
CI: 1.7-4.2 per 
100,000 persons 
 
LAR (boys)= 0.4, 95% 




44 CT Scan Su et al. (2014) Head Thyroid LAR (girls)= 8.7, 95% 
CI: 2.8-48.5 per 
100,000 persons 
 
LAR (boys)= 1.1, 95% 




45 CT Scan Su et al. (2014) Chest Thyroid LAR (girls)= 14.1, 95% 
CI: 7.0-65.4 per 
100,000 persons 
 
LAR (boys)= 2.1, 95% 




46 CT Scan Huang et al. (2014) All body Brain tumors HR =2.56, 95% CI: 




47 CT Scan Huang et al. (2014) All body Leukemia HR =1.90, 95% CI: 











No. Modality Author Exposure 
 
Outcome Result Elevated Risk 
49 CT Scan Huang et al. (2014) All body All Cancer HR =1.29, 95% CI: 




50 CT Scan Niemann et al. (2015) Chest All Cancer Exposed age of 0, 
LAR (males) = 5.76 
(thyroid), 3.07 
(leukemia), and 14.36 
(lung) incidence per 
100,000 persons 
 
LAR (females) = 26.22 
(thyroid), 2.05 
(leukemia), and 28.72 




51 CT Scan Niemann et al. (2015) Chest All Cancer Exposed age of 5, 
LAR (males) = 2.92 
(thyroid), 1.30 
(leukemia), and 9.73 
(lung) incidence per 
100,000 persons 
 
LAR (females) = 13.32 
(thyroid), 0.84 
(leukemia), and 19.19 




52 CT Scan Niemann et al. (2015) Chest All Cancer Exposed age of 10, 
LAR (males) = 1.78 
(thyroid), 1.05 
(leukemia), and 7.79 






No. Modality Author Exposure 
 
Outcome Result Elevated Risk 
LAR (females) = 8.24 
(thyroid), 0.62 
(leukemia), and 15.02 
(lung) incidence per 
100,000 persons 
 
53 CT Scan Niemann et al. (2015) Chest All Cancer Exposed age of 15, 
LAR (males) = 0.81 
(thyroid), 0.67 
(leukemia), and 4.53 
(lung) incidence per 
100,000 persons 
 
LAR (females) = 3.61 
(thyroid), 0.45 
(leukemia), and 9.23 




54 CT Scan Niemann et al. (2015) Chest Mortality Exposed age of 0, 
LAR (males) =0.92 
(leukemia), and 14.54 
(lung) mortality 
incidence per 100,000 
persons 
 
Exposed age of 0, 
LAR (females) =0.59 
(leukemia), and 25.19 
(lung) mortality 





55 CT Scan Niemann et al. (2015) Chest Mortality Exposed age of 5, 
LAR (males) =0.62 





No. Modality Author Exposure 
 
Outcome Result Elevated Risk 
incidence per 100,000 
persons 
 
Exposed age of 5, 
LAR (females) =0.39 
(leukemia), and 16.85 
(lung) mortality 
incidence per 100,000 
persons 
 
56 CT Scan Niemann et al. (2015) Chest Mortality Exposed age of 10, 
LAR (males) =0.62 
(leukemia), and 7.90 
(lung) mortality 
incidence per 100,000 
persons 
 
Exposed age of 10, 
LAR (females) =0.38 
(leukemia), and 13.17 
(lung) mortality 




57 CT Scan Niemann et al. (2015) Chest Mortality Exposed age of 15, 
LAR (males) =0.45 
(leukemia), and 4.58 
(lung) mortality 
incidence per 100,000 
persons 
 
Exposed age of 15, 
LAR (females) =0.31 
(leukemia), and 8.12 
(lung) mortality 






No. Modality Author Exposure 
 
Outcome Result Elevated Risk 





















Table 19. Appendix B - Sex Differences   
Modality 
 
Author Exposure Outcome Result (Overall) Female Male 
Dental Memon et al. (2010) Dental Thyroid OR = 2.10, 95% CI: 1.4-
3.1 
OR = 2.00 OR = 2.4 
X-rays Inskip et al. (1995) Head Thyroid RR = 1.00 to 1.22 N/A N/A 
X-rays Inskip et al. (1995) Chest Thyroid RR = 0.99 to 1.11 N/A N/A 
X-rays Inskip et al. (1995) Abdomen Thyroid RR = 0.75 to 1.10 N/A N/A 
X-rays Hammer et al. (2009) All body All Cancer IRR = 1.00 (reference) to 
1.01, 95% CI: 0.60- 1.71 
 
SIR = 1.00 SIR = 0.99 
X-rays Hammer et al. (2009) All body Leukemia and lymphoma IRR = 1.00 to 1.04 N/A N/A 
X-rays Hammer et al. (2009) All body Solid tumors IRR = 0.98 to 1.05 N/A N/A 
X-rays Hammer et al. (2011) All body All Cancer SIR = 0.97 N/A N/A 
X-rays Hammer et al. (2011) All body Leukemia and lymphoma SIR = 1.05 N/A N/A 





Author Exposure Outcome Result (Overall) Female Male 
CT Scan Su et al. (2002) Sinus Thyroid LAR (girls)= 2.7, 95% CI: 
1.7-4.2 per 100,000 
persons 
 
LAR (boys)= 0.4, 95% 
CI: 0.2-1.1 per 100,000 
persons 
 
LAR = 2.7 LAR = 0.4 
CT Scan Su et al. (2002) Head Thyroid LAR (girls)= 8.7, 95% CI: 
2.8-48.5 per 100,000 
persons 
 
LAR (boys)= 1.1, 95% 
CI: 0.4-3.6 per 100,000 
persons 
 
LAR = 8.8 LAR = 1.1 
CT Scan Su et al. (2002) Chest Thyroid LAR (girls)= 14.1, 95% 
CI: 7.0-65.4 per 100,000 
persons 
 
LAR (boys)= 2.1, 95% 
CI: 1.0-8.5 per 100,000 
persons 
 
LAR = 14.1 LAR = 2.1 
CT Scan Chodick et al. (2007) Head Mortality ELD (boys) = 0.78 to 
2.61; ELD (girls) = 0.48 
to 1.81 
 
ELD = 1.81 ELD = 2.61 
CT Scan Chodick et al. (2007) Rest of body Mortality ELD (boys) = 0.13 to 
2.18; ELD (girls) = 0.33 
to 2.90 
 
ELD = 2.90 ELD = 2.18 
CT Scan Pearce et al. (2012) Brain, Chest, 
Abdomen, and 
Extremity 
Leukemia ERR = 0.031 (male) per 
mGy and 0.042 (female) 
per mGy 
 
ERR = 0.042 
per mGy 
ERR = 0.031 
per mGy 
CT Scan Pearce et al. (2012) Brain, Chest, 
Abdomen, and 
Extremity 
Brain tumours ERR = 0.016 (male) per 
mGy and 0.028 (female) 
per mGy 
ERR = 0.028 
per mGy 






Author Exposure Outcome Result (Overall) Female Male 
 
CT Scan Mathews et al. (2013) Brain Thyroid IRR = 1.33 N/A N/A 
CT Scan Mathews et al. (2013) Brain Leukemia IRR = 1.16 N/A N/A 
CT Scan Mathews et al. (2013) Brain Solid cancer IRR = 1.13 N/A N/A 
CT Scan Mathews et al. (2013) Brain All Cancer IRR = 1.23 N/A N/A 
CT Scan Mathews et al. (2013) Chest Thyroid IRR = 1.41 N/A N/A 
CT Scan Mathews et al. (2013) Chest Leukemia IRR = 0.74 N/A N/A 
CT Scan Mathews et al. (2013) Chest Solid cancer IRR = 1.96 N/A N/A 
CT Scan Mathews et al. (2013) Chest All Cancer IRR = 1.62 N/A N/A 
CT Scan Mathews et al. (2013) Extremity Thyroid IRR = 1.19 N/A N/A 
CT Scan Mathews et al. (2013) Extremity Leukemia IRR = 1.42 N/A N/A 
CT Scan Mathews et al. (2013) Extremity Solid cancer IRR = 1.36 N/A N/A 
CT Scan Mathews et al. (2013) Extremity All Cancer IRR = 1.33 N/A N/A 
CT Scan Mathews et al. (2013) Abdomen Thyroid IRR = 1.47 N/A N/A 
CT Scan Mathews et al. (2013) Abdomen Leukemia IRR = 3.24 N/A N/A 
CT Scan Mathews et al. (2013) Abdomen Solid cancer IRR = 1.45 N/A N/A 
CT Scan Mathews et al. (2013) Abdomen All Cancer IRR = 1.61 N/A N/A 
CT Scan Mathews et al. (2013) Spine Thyroid IRR = 1.78 N/A N/A 
CT Scan Mathews et al. (2013) Spine Leukemia IRR = 1.31 N/A N/A 
CT Scan Mathews et al. (2013) Spine Solid cancer IRR = 1.02 N/A N/A 
CT Scan Mathews et al. (2013) Spine All Cancer IRR = 1.13 N/A N/A 
CT Scan Miglioretti et al. (2013) Head Solid cancer LAR = 1.1 to 17.5 N/A N/A 
CT Scan Miglioretti et al. (2013) Head Leukemia LAR = 0.5 to 1.9 N/A N/A 
CT Scan Miglioretti et al. (2013) Abdomen Solid cancer LAR = 13.1 to 33.9 N/A N/A 
CT Scan Miglioretti et al. (2013) Abdomen Leukemia LAR = 0.7 to 0.8 N/A N/A 
CT Scan Miglioretti et al. (2013) Chest Solid cancer LAR = 6.1 to 30.5 N/A N/A 
CT Scan Miglioretti et al. (2013) Chest Leukemia LAR = 0.4 to 0.6 N/A N/A 
CT Scan Miglioretti et al. (2013) Spine Solid cancer LAR = 5.3 to 37.5 N/A N/A 
CT Scan Miglioretti et al. (2013) Spine Leukemia LAR = 0.4 to 0.7 N/A N/A 
CT Scan Huang et al. (2014) All body Brain tumours HR =2.56 HR = 2.48 HR = 2.62 
CT Scan Huang et al. (2014) All body Leukemia HR =1.90 HR = 1.62 HR = 2.02 
CT Scan Huang et al. (2014) All body Solid cancer HR =0.65 HR = 0.69 HR = 0.62 





Author Exposure Outcome Result (Overall) Female Male 
CT Scan Niemann et al. (2015) Chest All Cancer Exposed age of 0, LAR 
(males) = 14.36 (lung) 
incidence per 100,000 
persons 
 
LAR (females) = 28.72 




LAR = 28.72 
(At age=0) 
LAR = 14.36 
CT Scan Niemann et al. (2015) Chest Mortality Exposed age of 0, LAR 
(males) = 14.54 (lung) 
mortality incidence per 
100,000 persons 
 
Exposed age of 0, LAR 
(females) = 25.19 (lung) 




LAR = 25.19 
(At age=0) 
LAR = 14.54 
CT Scan Krille et al. (2015) All body All Cancer SIR = 1.87 N/A N/A 
CT Scan Krille et al. (2015) All body Leukemia SIR = 1.72 N/A N/A 
CT Scan Krille et al. (2015) All body Lymphomas SIR = 3.26 N/A N/A 
CT Scan Krille et al. (2015) All body Lymphomas SIR = 1.35 N/A N/A 
CT Scan Krille et al. (2015) All body Lymphomas SIR = 1.68 N/A N/A 
 
 
 
